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CHAPTER I 
INTRODUCTION 
The inflammatory response is a complex interdependent seQuence 
of local vascular, cellular and tissue events that launch reparative 
processes at the host's damaged tissue. The acute inflammatory re-
sponse is heralded by vascular dilatation and marked alterations in 
vascular permeability leading to the exudation of protein and cellular 
elements at the inflammatory site. The macrophage~ i.e. the mono-
nuclear phagocyte, and polymorphonuclear leukocyte (PMNL) constitute 
the two major phagocytic cell populations that accumulate at the 
site of tissue injury .. The cellular development of the local in-
flammatory reaction classically features an early infiltration by the 
PMNL which is subseQuently replaced by the inflammatory macrophage as 
the principal phagocytic mediator of the host's defense reactions 
(105 ). Macrophages and PMNL at the inflammatory locus perform the 
vital functions of clearance, degradation and detoxification of in-
vading foreign organisms and cellular debris by employing endocytic 
and intracellular digestive mechanisms. However, the homeostatic con-
trol mechanisms and cellular interactions influencing the metabolic 
demands among inflammatory cell populations are poorly understood. 
The maintenance of PMNL and macrophage function is ultimately con-
tingent upon t~e continual provision of substrate supply and cellular 
energy. The relative importance of glycolytic and oxidative pathways 
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as energy sources varies markedly among the different macrophage and 
PMNL populations ( 85 ). Early in vitro studies centering on macro-
phage metabolism focused attention on metabolic alterations subsequent 
to phagocytosis (66). Glycolysis and respiration were transiently 
stimulated during the phagocytic event in macrophages, however certain 
macrophage populations are capable of deriving their energy for pha-
gocytosis exclusively from glycolysis under anaerobic conditions either 
in vitro or at the inflammatory site where low oxygen tensions prevail. 
Macrophage endocytic capacities include both phagocytosis and 
pinocytosis - terms utilized to describe the cellular ingestion of 
particulate matter and soluble components of their external environ-
ment, respectively. In addition to its role in microbial host defense, 
endocytosis affords a mechanism whereby the inflammatory macrophage 
enriches its fuel supply by ingestion and degradation of macromolecules 
found at the inflammatory site. Glycogen, an important carbohydrate 
fuel reserve, is one such macromolecule which is found in abundance in 
the PMNL (109). Histological studies have provided evidence that the 
glycogen-laden PMNL shedscytoplasmic fragments during the early course 
of the inflammatory response while the macrophage rapidly engulfs this 
potential source of fuel molecules (141). 
Although glycogen content and the mechanisms responsible for 
glycogen synthesis and degradation have been extensively investigated 
in various leukocyte populations, glycogen content and its regulation 
within macrophages have not received similar quantitative attention. 
Thus the intents of this study are to evaluate in vitro the physio-
logical responses of macrophages to exogenously added glycogen and to 
2 
assess glycogen metabolism and those control mechanisms responsible for 
glycogen synthesis and utilization within the macrophage derived from 
the inflammatory locus. 
3 
CHAPTER II 
HISTORICAL REVIEW 
A. The Role of the Macrophage in Inflammation 
\ 
1. His·torical development and knowledge of the macrophage 
system 
Although it was known that different forms of leukocytes oc-
curred in blood was in evidence as early as 1865.(108), the early 
functional history of the mononuclear phagocyte pivots around the ex-
haustive studies of Metchnikoff (82). In a series of comparative 
studies concerned with the cellular response following tissue injury, 
Metchnikoff investigated the phagocytic activity of inflammatory cells 
derived from both invertebrate and vertebrate species. He demonstrated 
the ultimate dominance of the phagocyte in the defense reactions of 
the host to inflammatory stimuli. Furthermore, he also was the first 
to distinguish between the macrophage, i.e., big eater, and the micro-
phage, the smaller polymorphonuclear leukocyte. In the following dec-
ade, Goldman (49) and others employed vital staining techniques and 
illustrated the ubiquitous occurrence and organ localization of mono-
nuclear phagocytes. As an outcome of these early histological studies 
Aschoff (3) coined the term reticuloendothelial system (RES) to des-
cribe the concept of a widely distributed collection of mononuclear 
phagocytes which are united by similar morphological and functional 
properties and potentialities. The RES includes both the fixed 
macrophage populations localized primarily in the blood 
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sinuses of the liver, lung, spleen, and bone marrow an~ the mobile mac-
rophage pool found in the serous cavities of the organism. Thus fol-
lowing Aschoff's formulation of the RES concept as a phagocytic 
functional system and metabolic apparatus involved in host defense 
mechanisms, all subsequent investigations have resulted in determining 
the potential and multiple roles of the mononuclear phagocyte in phy-
siological and pathophysiological settings. 
2. Origin of the inflammatory macrophage 
The origin and identity of the precursor cell which gives rise 
to the macrophage of the inflammatory exudate have been studied and 
debated for more than thirty years. Ebert and Florey (39) using rabbit 
ear chambers observed that monocytes infiltrated from the peripheral 
blood into the inflammatory site and differentiated into macrophages. 
However, it was argued by Rebuck and his colleagues (96, 98) that 
inflammatory macrophages were derived primarily from lymphocytes. 
Rebuck utilized the "skin window" technique in which glass coverslips 
were applied to areas of abraded human skin and then periodically 
removed and examined microscopically. It was concluded from these 
studies that small lymphocytes evolved through a series of intermediate 
cell types into inflammatory macrophages. 
Recent in vivo and in vitro labelling studies have supported 
the conclusions that under physiological conditions and during the 
acute inflammatory response, the inflammatory macrophage is principally 
derived from peripheral blood monocytes. That mononuclear phagocytes 
ultimately originated from bone marrow precursors was first demonstrated 
by Balner (5) in radiation chimeras give~ allogenic bone marrow cells. 
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Both transfusion studies with 3H-thymidine labelled bone marrow cells 
into syngenic rats (129) and labelling studies in X-irradiated animals 
with shielding of the bone marrow (126) have provided direct evidence 
not only for the existence of monocyte precursors in the bone marrow 
but also that the peritoneal macrophage population is derived from 
blood monocytes. 
Induction of an inflammatory response in the peritoneal cavity 
of mice resulted in a two- to threefold increase in the number of peri-
toneal macrophages by 72 hours following the introduction of an ir-
ritant (19). In vitro incubation of these periton~al macrophages in 
the presence of 3H-thymidine indicated a labelling index comparable to 
peritoneal macrophages from unstimulated animals, suggesting that the 
increase in macrophage population as a result of the inflammatory 
stimuli is not the result of increased mitotic activity (126). How-
ever, when peripheral blood monocytes were labelled in vivo with re-
peated injections of 3H-thymidine and a peritoneal inflammatory re-
sponse was induced, these experiments resulted in a 45 to 65% increase 
in the labelling of inflammatory peritoneal macrophages. Thus these 
experiments add overwhelming evidence in favor of the blood monocyte 
origin of the inflammatory macrophage. 
3. Morphology and maturation of the inflammatory macrophage 
Maximow and Bloom (80) provided the first detailed account 
of macrophage morphology and distinguished macrophages from the blood 
lymphocyte by their "active amoeboid protoplasm" and inclusion bodies. 
Macrophages are large (20-40~ cells having an eccentrically located 
horseshoe-shaped nucleus with an azurophilic granular cytoplasm 
6 
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containing numerous dense bodies and mitochondria (17). An extensive 
Golgi apparatus occupies the perinuclear area with lysosomal-like 
granules and mitochondria located at the periphery of the Golgi zone. 
At the light microscope level, the macrophage cell membrane is charac-
terized by a ruffled appearance. When macrophages are allowed to ad-
here to a glas·s surface, the cell membrane becomes dramatically well 
spread out and intensely ruffled (46). 
Recently, the ultrastructure of the peritoneal macrophage has 
been under intense investigation (13, 22, 37) and has revealed a com-
plex cytoplasmic structure and many prominent cell membrane processes. 
The macrophage membrane surface is studded with spherical indentations 
O.~in diameter suggesting ongoing active pinocytic vacuole formation. 
A granular endoplasmic reticulum and Golgi apparatus are well developed 
and have been shown to be the site of formation of the primary lysosome. 
In the mature macrophage many smooth surfaced vesicles (50-100 nm in 
diameter), the primary lysosomes, are distributed throughout the Golgi 
zone. The most prominent cytoplasmic inclusions are the large number 
of electron-dense granules demonstrated to be lysosomal in character 
by their positive acid phosphatase reaction (14). Such heterogeneous 
granules are seen to contain varying amounts of lipid or dense staining 
material and are clearly secondary lysosomes. Labelled marker par-
ticles have been demonstrated to be incorporated within these lysosomal 
structures by combination with phagocytic or pinocytic vacuoles formed 
at the membrane surface (16). 
Peritoneal macrophages in culture have been extensively used 
to study the maturation process of monocyte to macrophage differentiation. 
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Lewis (77) first observed, by culturing mixed blood cells, that blood 
monocytes altered their morphological appearance and matured into large 
macrophages, epithelioid and giant cells. More recent studies have con-
cluded that the induction of macrophage maturation by in vitro culturing 
techniques or in vivo, by lipopolysaccharide stimulated animals, resulted 
in similar morphological and biochemical alterations (19, 21). It was 
demonstrated by these authors that mouse peritoneal cells underwent a 
temporal sequence of morphological alterations including an increase in 
the number of phase-dense, acid phosphatase-positive granules and mito-
chondria. In addition, the size of the Golgi apparatus was markedly 
increased as well as the number of large lipid inclusions that were 
associated with the rough endoplasmic reticulum. Thus it is apparent 
that the arrival of the blood monocyte to the inflammatory site alters 
the macrophage into a large cell with more digestive capacity and 
phagocytic potential resulting in a dramatic stimulation in the 
functional properties of the inflammatory macrophage. 
4. Migration behavior of the macrophage 
Subsequent to all injury, alterations occur in the immediate vas-
culature and local tissue milieu leading to the emigration of phagocytic 
cells and the extravasation of plasma constituents. Although the PMNL 
is the preponderant cell type mobilized during the initial stage of the 
inflammatory reaction, within 24 hours, macrophages infiltrate the in-
flamed area and develop into the dominant phagocytic cell (105). The 
mechanisms underlying this temporal sequence and the eventual lo-
calization of the macrophage are poorly understood. Difference in PMNL 
and macrophage migration rates have been postulated as to why these t1vo 
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cell types do not appear simultaneously during the developing inflam-
matory reaction (138). 
chemotaxis, the directional movement of cells toward a chemical 
substance, has been the in vitro approach utilized to study the mechanism 
of phagocytic cell migration (54, 81). The chemotactic effect of a 
variety of substances is thought to be due to the formation of mediators 
(cytotaxins) produced by the interaction of these substances with normal 
plasma or serum (117). Several authors have suggested that there is no 
striking difference in the chemotactic response in vitro of macrophages 
l 
and PMNL (54, 69). However, Ward (133) has recently reported several 
chemotactic factors specific for mononuclear cells. One of these fac-
tors was derived from PMNL lysates indicating a functional relationship 
between these two cell's migratory behavior. Furthermore, the absence 
of circulating neutrophils has been reported to markedly reduce the 
appearance of mononuclear cells in experimentally induced inflammatory 
reactions (87). 
Other chemotactic factors to which mononuclear cells respond in-
elude a factor generated in serum by interaction with antigen-antibody 
complex, fragmentation products of the third and fifth components of 
complement, and soluble bacterial factors. The interaction of lympho-
cytes derived from animals exhibiting delayed hypersensitivity reactions 
wit~ specific antigen produces a material, migration inhibiting factor, 
inhibiting the random motion of normal macrophages in vitro (30). 
From these studies, it is obvious that a variety of processes 
at the inflammatory site generate soluble chemotactic factors whose 
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activities can be demonstrated in vitro, however the relative importance 
of the factors under in vivo conditions remains to be identified. Al-
though the cellular energetics involved in macrophage migration has not 
been adequately explored, recent information relative to the biochemical 
events of how chemotactic agents organize cell movements has assigned 
a major role in the mobility of phagocytes to contractile proteins and 
a microtubular system which possesses divalent cation-sensitive ATPase 
activity (119) .. 
5. Endocytosis and digestion by the macrophage 
The physiological expression and functional classification of 
the macrophage are ultimately dependent upon its ability to engulf ma-
terial from the external environment. This endocytic process encom-
passes both phagocytosis, the ingestion of particulate matter, and 
pinocytosis, the ingestion of soluble components of the external medium. 
The literature pertaining to phagocytosis is enormous and has been re-
peatedly reviewed ( 9, 17, 83, 84, 119). Although pinocytosis was first 
described over forty years ago ( 77), only recently has this endocytic 
process been extensively examined and reviewed (17, 41). 
a. Phagocytosis: 
Phagocytosis is a complex cellular phenomenon requiring on the 
part of the macrophage the expenditure of energy and the interaction of 
the particulate matter with certain properties of its limiting membrane. 
Investigations into the mechanism of phagocytosis have clas-
sically divided the endocytic event into the following sequence-
recognition and attachment, ingestion, and digestion of foreign material. 
The macrophage displays selectivity in what will be phagocytized 
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by recognizing certain characteristics on the surface of the material 
to be ingested. The importance of surface requirements for phago-
cytosis was first recognized by Wright and Douglas (140) who observed 
that bacteria had to interact with unknown serum components, which 
they named "opsonin", before phagocytosis would occur in vitro. Recent 
investigations· have identified certain immunoglobulins that are able 
to bind selectively to the macrophage surface membrane (10). These 
antibodies cytophilic for macrophages have been identified as IgG 
and represent the heat stable portion of hyperimmune serum opsonic 
activity although other immunoglobulins can also bind to the macro-
phage surface (8). A heat labile component of serum recently demon-
strated to express opsonic activity has been identified as the C3 com-
ponent of the complement protein (65). Although the mechanism by which 
macrophages respond to an opsonic surface is not known, there is evi-
dense that the Fe fragment of the IgG molecule attaches to the membrane 
surface of the macrophage and somehow the cell recognizes a conforma-
tional change in the antibody molecule when it combines with the par-
ticular antigenic determinant (91). The attachment of large particu-
late matter, i.e. red blood cells, to the macrophage surface has been 
studied (93, 127) with the result that attachment of aldehyde-treated 
red blood cells to the macrophage cell membrane is temperature de-
pendent but independent of serum or cation, while the ingestion 
process required the presence of both serum and cations in the medium. 
Thus the coupling of macrophage receptor molecules with opsonized 
' 
particles may not only serve a recognition role but also function to 
trigger the ingestion phase in some phagocytic systems. Ingestion of 
particulate matter by phagocytic cells is an energy dependent process 
initiating a complex sequence of morphological events. Following 
contact with the macrophage's cell surface, the particle is sur-
rounded by the plasma membrane by pseudopodia which fuse at the dis-
tal side of the particle to form the phagocytic vacuole or phagosome. 
As the phagosome· moves centripetally into the cytoplasm, primary 
lysosomes interact and fuse with the phagosome (60), resulting in 
the formation of a phagolysosome. A network of microfilaments has 
been observed in macrophage pseudopodia during ingestion and is 
thought to be the intracellular contractile element involved in mac-
rophage movement and membrane deformability (95). Cohn and Wiener 
(25) have investigated the intracellular events subsequent to in-
gestion and have demonstrated that acid hydrolyases are released from 
the primary lysosomes and are redistributed about the newly-formed 
phagocytic vacuole. Thus the degranulation of the vacuole contents 
involves the transfer of digestive enzymes from the lysosome ·converting 
the phagocytic vacuole into a digestive organelle. 
b. Pinocytosis 
Although both PMNL and macrophages actively engage in phago-
cytosis, of the two, only the macrophage is capable of pinocytic ac-
tivity (84). Pinocytosis serves as a mechanism whereby the macrophage 
transports exogenous material into lysosomal granules. Small invagi-
nations of the membrane surface form pinosomes which migrate inward and 
fuse with Golgi residues containing newly synthetized acid hydrolases 
forming secondary lysosomes. Pinocytosis in peritoneal macrophages in 
~ has been demonstrated to be regulated by medium constituents (24) 
12 
and depressed by inhibitors of glycolytic or oxidative phosphorylation 
(16). The rate of pinocytic activity in vitro is significantly in-
creased by a variety of molecules: l) anionic molecules including al-
bumin, acidic polysaccharides, RNA, and DNA and 2) nucleotides such 
as ATP. The presence of optimal concentrations of serum in the in-
cubation media not only stimulated pinocytic activity but also in-
creased the number of lysosomes as well as the levels of acid hydro~ 
lases, suggesting a direct correlation between serum concentrations, 
pinocytosis, and enzyme accumulation. Macrophage lysosomes contain 
a variety of acid hydrolases that are capable of degrading macro-
molecules to low molecular weight products which then are excreted 
or utilized by the cell. Recent observations have been made on the 
uptake and intracellular fate of soluble proteins by peritoneal 
macrophages (40). Iodinated human serum albumin was pinocytosized 
and transferred into lysosomes where the protein was degraded and a 
TCA-soluble isotope excreted. These studies point out the probable 
role of macrophage proteases and peptidases in digestion of foreign 
protein with the concomitant return of TCA-soluble peptides or amino 
acids to the extracellular environment. The mechanisms of uptake, 
storage and hydrolysis of carbohydrates were recently studied in the 
mouse peritoneal macrophage (20 ). Nonutilizable disaccharides were 
pinocytized and formed large acid phosphatase-positive vacuoles in 
the perinuclear region. Monosaccharides with molecular weights up 
to 220 did not produce lysosomal vacuolization. Those oligosac-
charides which did produce vacuolization were shown to be resistant 
to the complement of macrophage acid hydrolases and are quantitatively 
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retained within the cell during the incubation period. Thus at the in-
flammatory site the macrophage is capable of responding to a variety of 
stimuli by displaying a state of heightened physiological activity. 
This maturation process is accompanieq by profound alterations in 
function and morphology which have been referred to as differentiation. 
It is evident that the potential of macrophages to adapt and respond 
to external stimuli at the inflammatory locus by functional hyper-
trophy and subsequent modification of the immediate environment is of 
vital importance in the.functioning of macrophages at sites of tissue 
injury and repair. The increased pinocytic activ~ty and content of 
hydrolytic enzymes of the activated macrophage suggest an increased 
synthetic activity requiring an abundant and continuous supply of 
metabolic energy. Therefore, investigations into the pathways of 
energy supply and production would add further insight into the 
energetics of activation and maturation of the inflammatory macro-
phage. 
B. Macrophage Metabolism 
1. Mononuclear phagocyte vs. polymorphonuclear leukocyte 
The biochemical characterization of leukocyte function has 
yielded valuable information concerning the metabolic consequences 
underlying many macrophage and PMNL functions in host defense physi-
ology. However, a direct comparison of leukocyte metabolism is com-
plicated by the fact that several morphologically different types of 
white blood ce+ls exist and are distinctive in their complement of 
enzymes and other features of their metabolism. Furthermore, a homo-
geneous white cell population may display significant alterations in 
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its metabolic patterns depending upon the functional state of the cell 
(e.g. resting vs. phagocytizing, stage of differentiation, etc.) or 
whether the cells were derived from the normal or diseased state. 
Therefore such factors must be considered in attempting to critically 
review or evaluate leukocyte metabolism. 
Until recently, the biochemical properties of the PMNL have 
received almost exclusive attention in evaluating leukocyte metabolism 
due to the relative ease of obtaining a homogeneous population from the 
peripheral blood or inflammatory exudate. The general aspects of leu-
kocyte metabolism have consequently been thoroughl~ reviewed (15, 67, 
124). Since the role of the PMNL in host defense reactions is inti-
mately related to its ability to engulf and destroy a wide variety of 
microorganisms, the metabolic events accompanying phagocytosis by 
leukocytes have received considerable attention and have been exten-
sively revie~ed (66, 67). In contrast, the biochemical literature per-
taining to macrophage metabolism is relatively sparse when compared 
to the PMNL. This is due in part to the smaller yields of a homo-
geneous population of macrophages from blood, tissue, or exudate pre-
parations. Recently, however, relatively pure suspension of macro-
phages have been obtained from lung, peripheral blood, and peritoneal 
cavity (7, 85 ) resulting in more extensive investigations into the 
functional biochemistry of the macrophage (4, 68). 
2. Macrophage carbohydrate metabolism and energy supply 
The relative contribution of either glycolysis or oxidative 
I 
respiration as the principal energy source is significantly different 
among the various macrophage populations examined. The primary energy 
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source for the blood monocyte and peritoneal macrophage is glycolysis; 
the alveolar macrophage however appears to be more dependent on oxi-
dative mechanisms (7, 85). Harris and Barclay (55 ) observed that 
most of the glucose utilized by peritoneal macrophages was converted 
to lactate, even in the presence of adequate oxygen, and that under an-
aerobic conditions glycolysis supplied cellular energy reQuirements. 
Thus, they concluded that peritoneal macrophages are facultative 
anaerobes which utilize glycolysis as their principal energy pathway. 
Recently, West et al. (135) confirmed the high glucose utilization 
(31-37Junoles/hr/108 cells) displayed by peritoneal'macrophages and 
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also demonstrated a high aerobic lactate production. In addition, a 
comparison of the rates of glucose utilization by PMN leukocytes, lympho-
cytes and macrophages indicated that the macrophage is the most active 
of the three cell types studied. 
Glucose oxidation via the hexose monophosphate shunt is present 
in the non-particulate fraction of PMN leukocytes and macrophages. The 
alveolar macrophage of the guinea pig is far more active in converting 
glucose-l-14c and glucose-6-14c to 14co2 than the peritoneal macrophage 
(85). The ratio of 14co2 production from glucose-l-14c to that from 
glucose-6-14c is about 6:1 for the resting alveolar macrophage and 20:1 
for the peritoneal macrophage. The oxidation of glucose-6-14c to 14co2 
is extremely low in rat exudate PMNL ( 99 ), demonstrating a glucose-l-
14co2/glucose-6-14co2 ratio of 92 in the resting state. Rat PMNL are 
also character1zed by a low rate of oxygen uptake, a high aerobic glyco-
lytic rate, and an active direct oxidative pathway, thus the resting 
metabolism of peritoneal PMNL appears to be similar to that of the 
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peritoneal macrophage. 
3. Macrophage lipid metabolism 
Studies in macrophage lipid metabolism have addressed themselves 
to two important unsolved problems in macrophage physiology: 1) the 
tremendous lipid turnover of the cell membrane subsequent to endocy-
tosis and 2) the function of macrophages at the site of fatty plaque 
formation and their role in the clearance of blood cholesterol. 
Day (32) and his colleagues have investigated the uptake and 
metabolism of 14c-labelled cholesterol either in aqueous solution or 
as a, component of chylomicra and determined that exogenous cholesterol 
was incorporated by macrophages and rapidly hydrolyzed. The in vitro 
synthesis of cholesterol from 14c-acetate was demonstrated by peritoneal 
macrophages (31), along with cholesterol esterifying activity (33). 
The principal fatty acids synthesized by peritoneal macrophages from 
14c-acetate were palmitic, oleic and linoleic acids. 
The uptake of 14c-labelled fatty acids has been investigated 
in the alveolar macrophage. 14c-linoleic and 14c-palmitic acid were 
readily taken up by the macrophage, esterified and incorporated into 
the triglyceride and phospholipid pool (42). Inhibitors of glycolysis 
effectively eliminated esterification, whereas inhibition of oxidative 
metabolism was without effect. Furthermore, triglyceride incorporation 
was investigated by the use of labelled tripalmitate, free or chylomicra-
bound, and the cellular incorporation of labelled palmitate was ex-
amined following 60 minutes of incubation. Approximately 60% of the 
labelled palmitate was found in the triglyceride fraction, 35% in 
phospholipids, and 5% as free fatty acids. 
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A prominent feature in atherosclerotic plaque formation is the 
presence of a large number of lipid-laden macrophages infiltrating the 
vascular endothelium. Duff et al. (36) concluded that these lipid-
laden macrophages, called foam cells, were derived from the blood 
monocyte population and were incorporated into the vessel wall while 
the endothelium grew over the macrophages. Recently, Cookson (27) has 
proposed a dual origin for foam cells in atherosclerosis. One cell 
type contained numerous cytoplasmic fibrils suggestive of a smooth 
muscle cell origin. The other cell type manifested itself as a mac-
rophage, exhibiting many cytoplasmic processes, inclusions, and posi-
tive acid phosphatase reactive granules. Cholesterol and its esters 
have been shown to be fibrogenic and produce large granuloma when in-
jected into connective tissue (1). These authors suggest that phos-
pholipid injection somehow stimulated macrophage metabolism of cho-
lesterol and thereby removes the cholesterol before it can exert a 
fibrogenic effect on the vascular wall. 
Thus the macrophage's role in the metabolism of a variety of 
lipids establishes an important trophic function by the RES and clearly 
implicates the macrophage as an important site of metabolic fuel up-
take and processing in health and disease states. 
4. Macrophage protein synthesis 
The fact that macrophages are quite active in the synthesis and 
subsequent release of active molecules necessary to host defense mecha-
nisms suggests,an active protein forming machinery. On morphological 
evidence alone, macrophages and monocytes are quite active in protein syn-
thesis as shown by the presence of abundan~ endoplasmic reticulum and 
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ribosomes. Cohn et al. (21) have demonstrated in macrophages cultured 
in vitro that, following a pulse of leucine- 3H, a flow of newly formed 
--
protein occurs from the site of protein synthesis in the endoplasmic 
reticulum through the Golgi apparatus, and finally to the primary ly-
sosome. These authors concluded that the majority of the newly syn-
thesized prote.in accumulated in Golgi vesicles prior to their fusion 
with endocytic vacuoles. 
Interferon represents a heterogeneous class of antiviral pro-
teins produced in many tissues in response to viral infection. Several 
investigators have now clearly established that macrophages can produce 
and secrete large amounts of interferon. Acton and Myrvik (2) demon-
strated that alveolar macrophages can produce interferon following the 
in vitro inoculation of parainfluenza-3 virus. Incubation of normal 
alveolar macrophages with this substance before challenging the macro-
phages with pox virus protected the cells against destruction. Perito-
neal macrophages are also capable of producing interferon which is de-
tectable in the culture medium two hours following the exposure of mac-
rophages to viral agents (116). 
Stecher and Thorbecke (118) have studied t·he in vitro incorpora-
tion of 14c-labelled amino acids into serum proteins by macrophages. 
By utilizing autoradiographic and immunoelectrophoretic techniques, 
they found that peritoneal macrophages synthesize in vitro Blc globulin 
(C'3) and transferrin far more actively than either thoracic duct 
lymphocytes or,blood leukocytes. Although the macrophage is important 
for complement component synthesis and probably the major site of com-
plement formation in lymphoid tissue, it must be realized that it is 
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probably not the only cell capable of producing these proteins. In all 
likelihood the parenchymal cells of the liver are also capable of syn-
thesizing serum complement proteins. 
Blood monocytes and peritoneal macrophages do not normally syn-
thesize DNA under culture conditions (126), although following stimu-
lation by an adjuvant, macrophages are able to divide and incorporate 
thymidine into DNA. Active RNA synthesis has been demonstrated in 
macrophages (17). Utilizing 3H-uridine and radioautographic techniques, 
macrophages incorporate uridine initially into the nucleus and nucleoli 
followed by migration of the label into regions of the cytoplasm con-
taining ribosomes. 
5. Phagocytosis associated metabolism in PMNL and macrophages 
Phagocytosis is associated with profound alterations in the 
metabolism of phagocytic cells. The nature and magnitude of these 
metabolic perturbations vary and are ultimately dependent upon a host 
of factors including: 1) the cell type (PMNL vs. macrophage), 2) the 
origin of the phagocytic cell (blood, lung, or peritoneal cavity), 
3) the type of particle ingested (bacteria vs. synthetic), and 4) the 
incubation conditions (serum concentration, gas phase, cell suspension 
or monolayer, etc.). 
a. PMN Leukocytes 
Until recently, the PMNL has been the phagocytic cell population 
which has been most studied in an effort to understand the metabolic 
events accompanying phagocytosis ( 6~. For example, it has been demon-
strated that the uptake of particulate matter by the PMNL is accompanied 
by a stimulation of oxygen consumption, as well as by increases in aerobic 
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and anaerobic glycolysis, glycogenolysis, hexose monophosphate shunt 
activity, lipid turnover, and formate oxidation (23, 63, 106, 107). 
Glycolytic inhibitors (e.g. sodium fluoride and iodoacetate) have a 
profound inhibitory effect on phagocytosis, whereas the respiratory in-
hibitors (e.g. sodium cyanide and antimycin A) have little effect. It 
is clear that ~hagocytosis by PMNL is an active process requiring a 
net expenditure of energy derived primarily from glycolysis. 
The dramatic respiratory burst that is associated with phagocy-
tosis has been linked functionally to a bactericidal mechanism in the 
PMNL. Klebanoff (70) has postulated an effective antimicrobial scheme 
consisting of a halide, myeloperoxidase, and the production of hydrogen 
peroxide. The increment in oxygen uptake subsequent to phagocytosis ap-
pears to be largely insensitive to inhibitors of cytochrome-linked respi-
ration and is accompanied by the direct oxidation of glucose via the 
hexose monophosphate shunt. Two oxidases have been demonstrated in the 
PMNL capable of producing hydrogen peroxide (12, 145). It ·has been sug-
gested that the activation of one of these two oxidases during phagocy-
tosis accounts for the increased oxygen utilization and direct oxidation 
of glucose-l-14c due to the generation of NADP either by indirect coupling 
with an NADPH lactic dehydrogenase or by direct NADPH oxidation. 
b. Macrophages 
The recent advent of improved techniques for separating mono-
nuclear cells from the peritoneal cavity, lung, or peripheral blood has 
elicited quantitative information concerning the metabolic events of 
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macrophages during phagocytosis. Oren et al. (85) compared the meta-
bolic characterizations of peritoneal macrophages and PMNL along with 
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alveolar macrophages harvested from the guinea pig. Following the in-
gestion of starch particles, these authors observed that both respi-
ration and glycolysis were stimulated in peritoneal macrophages as evi-
denced by a three-fold increase in oxygen uptake concomitant with a 
ten-fold increase in the recovery of 14coz from glucose-6-14c. Phago-
cytosis by peritoneal macrophages was not impaired by anaerobiosis, in-
hibitors of respiration (1o-3M cyanide) or by uncouplers of oxidative 
phosphorylation (1o-4M 2,4-dinitrophenol). However, the glycolytic in-
hibitors, sodium fluoride (1o-2M) and iodoacetate (1o-4M), exerted a 
dramatic inhibitory effect on phagocytosis. Thus it was concluded that 
the peritoneal macrophage derived its energy needs for phagocytosis 
from glycolysis. 
The alveolar macrophage, with a resting respiratory rate three 
times that of the peritoneal macrophage, demonstrated only a slight in-
crease in oxygen uptake or 14coz production from either glucose-l-14c 
or glucose-6-14c following phagocytosis. Furthermore, phagocytosis by 
alveolar macrophages was markedly depressed in the presence of inhibi-
tors of both oxidative and glycolytic metabolism. 
Cytochemical investigations involved with the metabolism of al-
veolar and peritoneal macrophages basically concur with the biochemical 
evidence that alveolar macrophages require oxidative metabolism to meet 
energy demands while peritoneal macrophages derive their energy needs 
predominantly from glycolytic metabolism. Portugalov et al. (92) demon-
strated that peritoneal macrophages displayed high activity of such 
glycolytic enzymes as phosphorylase and lactic dehydrogenase, whereas 
the alveolar macrophage demonstrated higher levels of tricarboxylic 
acid cycle enzymes than did the peritoneal macrophage. ' 
In contrast to the PMNL where phagocytosis was associated with 
a three-fold increase in the ratio of l4co2 from glucose-l-l4c to 
glucose-6-l4c, Oren et al. (85) could not demonstrate any significant 
increase in hexose monophosphate shunt activity in either the alveolar 
or peritoneal macrophage subsequent to phagocytosis. However, West 
et al. (135 ) calculated hexose monophosphate shunt activity in guinea 
pig peritoneal macrophages and were able to demonstrate a small but 
significant increase during phagocytosis. 
Recently Romeo et al. (101) have analyzed the link between the 
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stimulated respiration and HMP shunt activity in the macrophage. Their 
results show a stimulation of both processes within seconds after the 
addition of bacteria. Furthermore, NADPH oxidase activity has been 
demonstrated in macrophage 20,000 x g subcellular fraction sug-
gesting that the activation of this oxidase, producing hydrogen per-
oxide, may be the event linking the stimulation of macrophage respira-
tion to that of HMP shunt activity, a mechanism similar to that found 
in the PMNL. 
Stimulation of macrophage metabolic pathways is not only de-
pendent upon particle ingestion but also on the state of maturation of 
the mononuclear cell population. Nonstimulated macrophages washed from 
unstimulatedmouseperitoneum displayed no respiratory burst during 
phagocytosis (68). However,peritoneal macrophages harvested five days 
following the intraperitoneal injection of caseinate, demonstrated the 
typical respiratory response subsequent to the ingestion of particles. 
The metabolic requirements for macrophage pinocytic activity 
have been investigated in the mouse peritoneal macrophage (16) and 
are clearly distinctive from those required for phagocytosis. Pino-
cytosis by the peritoneal macrophage was depressed by inhibitors of 
respiration (1o-5M cyanide, 1o-7M antimycin A), by anaerobiosis, and 
by inhibitors of oxidative phosphorylation (0.6 g/ml oligomycin, 
10-6M 2,4-dinitrophenol). Pinocytosis can also be arrested by inhi-
bitors of protein synthesis suggesting that the synthesis of new plasma 
membrane is probably required for continuing membrane interiorization 
processes. 
6. Glycogen metabolism in the PMNL 
The preceding summary of selected aspects of the metabolism of 
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PMNL and macrophages have emphasized the major role performed by aerobic 
and anaerobic glycolysis in meeting the energy demands of phagocytic 
cells. The high rate of glucose utilization in the macrophage and the 
accelerated rates of glycolysis demonstrated by PMNL and macrophages 
during the endocytic event necessitate a ready supply of glucose in 
order to maintain functional integrity. Furthermore, at the inflam-
matory site, where low oxygen and substrate supply may prevail, it would 
be advantageous if exudate cells were able to store glucose in a reserve 
form to meet continual energy demands. Glycogen is the principal macro-
molecular storage form of carbohydrate in animal cells and, in concert 
with glycogen synthetic and degradative enzymes, functions as a dynamic 
ready source of glucose. 
Investigations approaching the study of glycogen metabolism and 
# 
its regulation in white blood cells have primarily focused attention on 
the leukocyte phagocytic cell population. Early studies using histological 
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techniques demonstrated that most of the glycogen in circulating white 
blood cells is found in neutrophils and platelets, while both lymphocytes 
and monocytes contained relatively small amounts of stainable glycogen. 
wachstein (130) demonstrated that eosinophils and basophils contained 
glycogen but in much smaller amounts than in the neutrophil. This his-
tochemical data in conjunction with the relative ease of procuring a 
homogeneous population of blood leukocytes stimulated the appearance of 
quantitative· estimates of leukocyte glycogen. 
Wagner (131) estimated leukocyte glycogen, utilizing the micro-
method of Pfluger (90), to be 4.2 micrograms per 106 granulocytic leuko-
cytes and calculated that the glycogen content of leukocytes was in the 
same order of magnitude as striated muscle (i.e. 0.5-1.0%). Valentine 
et al. (125) investigated the glycogen content of human leukocytes in 
health and in various disease states by the anthrone technique (113). 
The mean leukocyte glycogen per 1010 granulocytic leukocytes was 75.1 mg. 
Leukocyte glycogen remained relatively unchanged during. fasting and the 
postprandial rise in blood glucose. Leukocytes obtained from chronic 
myelocytic leukemic patients displayed a glycogen content approximately 
one half that of normal subjects. In contrast, leukocyte glycogen in 
polycythemia vera was elevated to a mean value per 1010 leukocytes of 
116.2 mg. 
Recently, an elegant study on leukocyte glycogen turnover and 
the macromolecular state of leukocyte glycogen was performed by Scott 
et al. (112).' The glycogen content of human leukocytes averaged 7.36 + 
2.05 mg glycogen per 109 neutrophils and, when placed in a glucose-free 
medium, decreased 38% following a two hour incubation. Leukocyte glycogen 
synthesis was investigated in vitro by determining the glucose level at 
which intracellular glycogen was not consumed and the glucose level 
which provided maximal glycogen resynthesis. The glucose load which 
gave no net change in leukocyte glycogen for 60 minutes of incubation 
was found to average 17.6 mg %, while the maximal change in glycogen 
content was obtained at a glucose load of 200 mg %. After preincu-
bation of leukocytes in glucose-free medium, glycogen resynthesis with 
glucose-l4c was estimated and revealed that nearly 90% of the intra-
cellular radioactivity was found in the isolated glycogen fraction. An 
electron micrograph study of leukocyte glycogen revealed a rather 
uniform particle size of about 20-30 ~ in diameter, unlike liver gly-
cogen particles which appear in a spectrum of sizes ranging from 40 to 
200 II¥-t in diameter (ll2). 
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In view of the observations that leukocyte glycogen levels ap-
peared to be markedly labile in various physiological and disease states, 
several investigators have attempted to elucidate those factors con-
trolling glycogenolysis and glycogenesis in the leukocyte. Williams 
and Field (137) measured leukocyte phosphorylase activity in normal 
humans and in two patients with glycogen storage disease with low liver 
phosphorylase activity. The mean level of leukocyte phosphorylase was 
29.6 micrograms of inorganic phosphorus per 107 leukocytes in normal 
patients and an abnormally low mean value of 6.3 micrograms of inorganic 
phosphorus per 107 in those patients manifesting glycogen storage 
disease. The authors concluded that the determination of leukocyte 
phosphorylase activity derived from a blood sample may assist in diag-
nosing certain glycogen storage diseases, ideally eliminating the need 
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for a liver biopsy. Glycogen phosphorylase was assayed in normal leu-
kocytes and those derived from patients with chronic granulocytic or 
lymphocytic leukemia (144). Their results indicated that normal leu-
kocyte phosphorylase existed predominantly in .the active form (i.e. 
active in the absence of 5'-AMP) suggesting that this leukocyte enzyme 
is closely rel·ated to liver phosphorylase. Phosphorylase levels in 
leukemic leukocytes did not differ significantly from the normals. 
The properties of leukocyte glycogen phosphorylase were further 
studied in rats with chloroma, a tumor composed entirely of immature 
granulocytes (143). Two forms of the enzyme were demonstrated to 
exist, an active form exhibiting 65-80% of its activity in the ab-
sence of 5'-AMP and an inactive form that was not significantly active 
even in the presence of the nucleotide. The authors noticed striking 
similarities in the properties of leukocyte glycogen phosphorylase when 
compared to liver phosphorylase. 
Sbarra and Karnovsky (106) observed that, when leukocytes are in-
gesting latex particles in a glucose-free medium, glycogen breakdown was 
accelerated during the first fifteen minutes of incubation. However, 
these same authors found that in the presence of glucose no change in 
glycogen content occurred during phagocytosis. Recently, Stossel et al. 
(120) incubated leukocytes with latex particles in the absence of glu-
cose and demonstrated that during the first fifteen minutes the rate 
of glycogenolysis was accelerated while glycogen phosphorylase or syn-
thetase activity did not significantly differ from leukocytes incubated 
without particles. Epinephrine and glucagon, hormones which increase 
phosphorylase activity in liver preparations, had no effect in leukocyte 
phosphorylase activity, although Williams and Field (13() did report 
. that glucagon increased phosphorylase activity. 
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The biosynthesis of glycogen via glycogen synthetase or trans-
ferase has been demonstrated in human PMNL (103) and in lymphocytes (57). 
In normal human PMNL,synthetase activity existed only in the glucose-6-
phosphate dependent D-form, whereas lymphocytes possessed the system 
for interconversion between the D and I-form (i.e. independent of glu-
cose-6-phosphate). However, in leukocytes from diabetic patients, gly-
cogen synthetase was found in both the I and D-form (45) and the D to I 
transformation was greatly increased by insulin treatment. Leukocytes 
from rat peritoneal exudates differed from human PMNL in that incubation 
greatly stimulated the D to I transformation in both normal and diabetic 
leukocytes (102). Recently Wang et al. (132) incubated human PMNL in a 
glucose-free buffer for two hours and observed a large decrease in gly-
cogen content and phosphorylase activity. The subsequent addition of 
a 2 mg/ml glucose load resulted in a three-fold increase in ·the I ac-
tivity, thus demonstrating that a D to I interconversion system, similar 
to those found in liver, muscle and rat PMNL preparations, is present in 
normal human PMNL. Insulin had no demonstrable effect on 
either the D to I conversion of glycogen synthetase or on the glycogen 
content of human PMNL. 
1. Glycogen metabolism in inflammatory cells 
Information regarding the role of glycogen in inflammatory exu-
date cells is meager .and consists primarily of histological studies 
demonstrating the presence of stainable glycogen deposits. Page and 
Good (87}, utilizing the skin window technique of Rebuck followed the 
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progression of phagocytic cells infiltrating into the iQflammatory site 
in neutropenic patients. They observed a marked depletion of mononuclear 
cells at the inflammatory site in the absence of circulating neutrophils 
and concluded that viable leukocytes somehow contributed to the sub-
sequent appearance of macrophages in the inflammatory response. Wulff 
(141), utilizing the periodic acid-Schiff (PAS) technique to stain for 
glycogen~ investigated the glycogen content of leukocytes and macrophages 
infiltrating into the inflammatory locus. Initially, neutrophils at the 
exudate site were observed to contain variable amounts of PAS positive 
reaction product and as the inflammatory reaction proceeded, the neu-
trophils stained more intensely. With the appearance of macrophages, 
neutrophil cytoplasmic fragments containing PAS positive reaction pro-
duct were eventually observed to be amassed in membraneous aggregations 
aroundthe macrophage population. Rebuck et al. (97) also demonstrated 
a direct transfer of neutrophil cytoplasmic glycogen to monocytes during 
the course of the inflammatory response in humans. Furthermore, they 
observed a failure to transfer glycogen to mononuclear cells in severely 
acidotic patients and suggested that the absence of membraneous-glycogen 
in the mononuclear cells accounted for the depressed phagocytic ability 
in diab.etic phagocytes and offered a mechanism for the increased suscep-
tibility of diabetics to infection. 
Recently, Scott and Cooper ( 111) studied the leukocyte glycogen 
responses in guinea pig inflammatory exudates and demonstrated a dra-
matic rise in exudate leukocyte glycogen content as compared to blood 
leukocyte glycogen levels. Glycogen synthetase activity was found to be 
significantly elevated in inflammatory leukocytes when compared to 
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peripheral blood leukocytes whereas, no significant change in glycogen 
phosphorylase activity was detected in blood or exudate leukocytes. 
Fasting the animals for up to three days appeared· to have no effect on 
the glycogen a~cumulating ability of inflammatory leukocytes. Thus the 
authors concluded that the dramatic rise in leukocyte glycogen levels 
at the inflammatory site is a significant event in the course of the 
inflammatory response and can be accounted for by the relative increase 
in the D-form of glycogen synthetase activity in the exudate leukocyte. 
c. Statement of the problem 
In contrast to the abundant data which exists relevant to gly-
cogen metabolism and its regulatory mechanisms in blood and exudate 
leukocytes, no quantitative information is available that has explored 
the role of glycogen or its metabolism within the inflammatory macro-
phage nor the mechanisms by which macrophages acquire glycogen at the 
inflammatory site. 
The overall purpose of this study is to evaluate in vitro the 
physiological responses of macrophages derived from the inflammatory 
site to exogenous glycogen. Studies were undertaken to demonstrate 
the mechanisms by which inflammatory macrophages acquire a large intra-
cellular glycogen level from the inflammatory environment. Additional 
studies were also performed to examine those mechanisms employed by 
inflammatory macrophages to maintain and utilize this carbohydrate re-
serve for continual macrophage function. 
Furthe~more, in the present study in vitro methods were developed 
and employed to demonstrate macrophage glycogen synthesis and degrada-
tion by determining the activity of glycogen phosphorylase and synthetase 
and also by identifying an O<.-glucosidase of probable lysosomal origin. 
In view of the observation that macrophages perform trophic 
functions by ingestion of particulate material and the subsequent re-
lease of digested material into the extracellular environment, studies 
were employed to examine a new trophic function of glucose export 
and the relevant contribution of extracellular glycogen ingestion to 
this glucogenic mechanism. 
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CHAPTER III 
EXPERIMENTAL METHODS 
A. Experimental Animals 
Male rats of the Sprague Dawley strain weighing between 250 
and 350 grams were obtained from the Holtzman Co., Madison, Wisconsin. 
The rats were housed at a room temperature of 74-75°F and maintained 
on Purina Laboratory Chow and tap water ad libitum. 
B. Preparation of Inflammatory Cell Populations 
1. Exudate production 
Inflammatory peritoneal exudates containing either PMNL or mac-
rophages were induced by a modification of the procedure described by 
Reed and Tepperman (99). Rats were anesthetized with ether and in-
jected intraperitoneally (16 ml/100 gm body wt) with a 1% solution of 
sodium caseinate (Eastman Kodak Co., Rochester, N.Y.) in 0.02M phos-
phate-buffered saline (PBS) at pH 7.4. Non-inflammatory mononuclear 
cells were obtained by lavage of normal rat peritonelw without prior 
stimulation with caseinate. Peritoneal exudates containing PMNL were 
collected three hours following the introduction of caseinate while 
inflammatory macrophages were harvested 96 hours after the injection 
of the irritant. 
2. Harvesting procedures 
Followitig decapitation, 20 ml of cold PBS containing 20 units/ml 
of heparinwere injected into the peritoneal cavity, mixed briefly, and 
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the exudate contents withdrawn with a large syringe and needle and 
delivered into 50 ml Nalgene centrifuge tubes at 40C. Cells were 
sedimented by centrifugation at 150-200 x g for 10 minutes at 40C 
and erythrocytes were effectively removed from the resulting cell 
pellets by a 10 second exposure to 5.0 ml of distilled water followed 
immediately by the addition of 15.0 ml of 1.2% saline to adjust iso-
tonicity. Following recentrifugation at 200 x g for 10 minutes at 
4oc, cells were resuspended in cold glucose-free Hanks solution (GFH),* 
pH 7.4, and washed twice in GFH prior to resuspension to their final 
volume. 
3. Cell counting, differential and protein determination 
Duplicate cell counts were ·obtained from 0.1 ml sample of the 
final cell suspension diluted into 10 ml of GFH by routine hemocytometry 
and expressed as 106 cells per ml of cell suspension. Cell differentials 
of PMNL, macrophages and lymphocytes were performed from Wright-stained 
smears. Cell protein was determined from a 1:100 dilution 'of cell sus-
pension according to the method of Lowry et al. (78) utilizing the Oyama 
and Eagle modification (86) with bovine albumin as a reference standard. 
C. Glycogen Determination in Inflammatory Leukocytes and Macrophages 
1. Chemical determination of glycogen 
Glycogen was isolated from inflammatory macrophages and PMNL by 
a modification of the procedure originally described by Good, Kramer, 
and Somogyi (50). Glycogen was extracted by adding 2.0 ml of 30% KOH to 
cell pellets (~0-120 x 106 cells) in 12 ml glass centrifuge tubes and 
*Glucose-free Hank's balanced salt solution (pH=7.4), concentrations in 
grams/L: NaCL 8.0, KCl 0.40,-Naz HP04 0.09, KHZ P04 0.06, Mg S04 0.1, 
CaClz 0.14, Mg CLz 0.1, NaHC03 0.35. 
heating in a boiling water bath for 15 minutes until the pellet dis-
solved. Following hydrolysis, tubes were cooled to room temperature 
and 2.0 ml of 95% ethanol (ETOH) was added, mixed, reheated to near 
boil, and stored at 4°C overnight to precipitate glycogen. Glycogen 
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was sedimented by centrifugation at 1000 x g for 10 minutes at 4°C and 
the resulting supernatant discarded. The glycogen pellet was washed 
twice in 60% ETOH and the final pellet drained briefly to remove the 
alcohol. 1.0 ml of distilled water and 1.0 ml of 2.0 N H2S04 were added 
to the dried glycogen pellets and heated in ~ boiling water bath for 3 
hours. Following acid hydrolysis of the glycogen, the tubes were cooled 
to room temperature and neutralized to pH 7.0 by titrating with 1.0 N 
NaOH and the final volume brought to 5.0 ml with distilled water. Dup-
licate 1.0 ml aliquots were added to 4.0 ml :of glucose oxidase reagent 
(Worthington Biochemical Co., Freehold, N.J.) and color development 
read after 60 minutes of incubation at 37°C using a Klett-Summerson 
colorimeter with blue filter (400-450 ~). Results are exp~essed as 
either fg of glycogen per mg of protein or /<g glycogen per 106 cells. 
2. Incorporation of 14c-U-glucose into macrophage glycogen 
4.0 ml of 96 hour inflammatory macrophages (30 to 40 x 106/ml) 
in GFH, pH 7.4, were incubated at either 370 or 4°C in 25 ml Erlenmeyer 
flasks containing 14c-U-glucose at a final concentration of 10 mM. 
14c-U-glucose (specific activity 285 mC/mmole) was diluted with non-
radioactive glucose in GFH to a specific activity of either 0.1 or 
1.0 ;tCi/10 mM glucose. Following the incubation interval, the contents 
of the flasks were transferred to 12 ml glass centrifuge tubes at 4°C 
and the macrophages washed twice in cold GFH to remove any extracellular 
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14c.:.glucose. 2.0 ml of 30% KOH was added to the final'macrophage pellet 
and glycogen precipitated by the method of Good, Kramer, and Somogyi (50) 
as described above. Following two washings in 60% ETOH, the final gly-
cogen pellet was dissolved in 1.5 ml of. distilled water and duplicate 
0.5 ml aliquots of the glycogen solution were added to 10 ml of PCS and 
counted in the Isocap 300 (Searle Analytic Inc., Des Plaines, Illinois) 
for 10 minutes. Activity was expressed as the dpms incorporated into 
macrophage glycogen per mg protein per incubation time. 
3. 14c-glycogen isolation from rat liver 
Rat liver 14c-glycogen was prepared by the.incorporation of 14c-
U-glucose into liver glycogen as described by Brown (11). Male rats 
weighing 300-350 gms were fasted overnight and anesthetized with sodium 
pentobarbital (12 mg/300 gm). 2-deoxyglucose (40 mg/100 gm body weight) 
was injected i.v. into the dorsal vein of the penis followed after 30 
minutes with an intraperitoneal injection of D-glucose (150 mg/100 gm 
body weight) containing 14c-U-glucose at a specific activit.y of 6.0 fCi/ 
mmole. Following three hours of light anesthesia maintained by subcu-
taneous injection of pentobarbital, the rats were decapitated, the livers 
quickly removed, weighed, cut into small pieces, and placed immediately 
into 250 ml beakers containing hot 30/o KOH and heated to near boil with 
stirring for 15 minutes. After tissue digestion, beakers were cooled to 
room temperature and 50 ml of 95% ETOH added, mixed and the contents 
poured into centrifuge tubes and the glycogen allowed to precipitate 
overnight at 4~C. Glycogen pellets were centrifuged for 10 minutes at 
200 x g and washed twice in three volumes of 60% ETOH. The final gly-
cogen pellets were dissolved in distilled water and dialyzed (mol. 
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weight cut off l2,QOO-l4,000) against water overnight at room tempera-
ture. Following dialysis, glycogen was reprecipitated by adding l 
volume of 95% ETOH, washed in 60% ETOH and dried in a vacuum desiccator. 
The resulting glycogen was weighed and di.luted in GFH and activity ex-
pressed as cpm per mg of glycogen by adding 1.0 ml of a known concentra-
tion of l4c-glycogen in GFH to 10.0 ml of Phase Combination System (PCS) 
Solubilizer and counted for 10 minutes in Isocap 300 Liquid Scintillation 
System, using efficiency calculations based on quench correction factors 
determined by the sample channels ratio method. 
4. Uptake of l4c-glycogen by inflammatory macrophages 
4.0 ml of inflammatory macrophages (30-40 x 106 cells/ml) in GFH, 
pH 7.4, were incubated in 25 ml Erlenmeyer flasks containing 10 mg/ml 
of l4c-glycogen, specific activity (2-3 x 103 cpm/mg glycogen), at either 
37oc or 4°C with shaking (60/min). Following the incubation period, 
contents of the flasks were transferred to 12 ml glass centrifuge tubes 
at 4°C and the flasks rinsed with cold GFH. Cells were washed twice in 
cold GFH to remove extracellular l4c-glycogen and 2. 0 ml of 30% KOH was 
added to the cell pellets and macrophage glycogen isolated by the method 
of Good, Kramer, and Somogyi (50) as described above. The final glyco-
gen pellet was dissolved in 1.5 ml of distilled water and duplicate 0.5 
ml aliquots were added to 10 ml of PCS and counted in the Isocap 300 for 
10 minutes. Activity is expressed as the~g of l4c-glycogen incorporated 
into macrophage glycogen per mg protein. 
D. Glycogen Regulatory Enzyme Determinations in Inflammatory Macrophage 
l. Macrophage phosphorylase activity 
Macrophage phosphorylase activity was determined in the direction 
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of polysaccharide synthesis by measuring the rate of liberation of in-
organic phosphorus from glucose-1-phosphate in the presence of glycogen 
by a modification of the method of Sutherland (121). 3.0 ml of 96 hour 
inflammatory macrophages (20-40 x 106 cells/ml) in GFH, pH 7.4, were 
incubated in 25 ml Erlenmeyer flasks containing 1.0 ml of additions at 
37oc in a Dubnoff metabolic shaking bath (60/min) with air as the gas 
phase. Incubations were terminated by the rapid transfer of the flask 
contents into 12 ml glass centrifuge tubes at 4°C, the flasks rinsed 
with cold GFH, and the cell suspensions centrifuged at 200 x g for 10 
minutes at 4°C. Following centrifugation, the su~ernatant was discarded 
and the macrophage pellets were resuspended in 2.0 ml of 0.1 M NaF at 
4oc. Macrophages were effectively disrupted by a 2 minute sonication 
at 4oc using a Biosonik IV Sonifer (Brownwill Scientific Inc., Rochester, 
N.Y.) with microprobe and centrifuged for 10 minutes at 3000 x g to re-
move cellular debris. 0.4 ml of the resulting sonicate supernatant was 
added to duplicate 12 ml glass centrifuge tubes at 4°C cont·aining 1. 0 ml 
of 0.05 M glucose-1-phosphate (pH 6.1) containing 5.7 mg/ml of glycogen 
and 0.05 M NaF and either 0.1 ml of 0.02 M adenosine-5 -phosphate or 
0.1 ml of distilled water. Reagent blank tubes without sonicate were 
included in each experiment. Reaction mixtures were incubated for 15 
minutes at 37°C and terminated by the addition of 2.0 ml of cold 5% TCA 
and centrifuged for 10 minutes at 500 x g at 4°C. Following centrifu-
gation, duplicate 0.2 ml aliquots of deproteinized supernatants were 
added to cuvettes containing 0.8 ml of distilled H20 and inorganic phos-
phorus was determined by the method of Fiske and Subbarow (47). 3.0 ml 
of molybdic acid reagent were added to each cuvette and, at 10 second 
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intervals, 1.0 ml of elon reagent was added to each tube and incubated 
for 15 minutes at 37°C. Color development was read immediately in a 
Klett-Summerson colorimeter using a red filter. Results are expressed 
as micrograms of inorganic phosphorus liberated per mg protein per 15 
minutes of incubation. 
2. Macrophage ~glucosidase activity 
Macrophage ~-glucosidase activity was measured by the formation 
of glucose from maltose, isomaltose, and glycogen as described by Hers 
(58). A 96 hour inflammatory macrophage cell suspension (1-10 x 106 
cells/ml) in saline was sonicated for 2 minutes at 4°C. 0.5 ml dupli-
cate aliquots of macrophage sonicate were added to 12 ml glass centri-
fUge tubes containing either (1) 0.5 ml of 8 mg/ml of glycogen in 0.1 M 
acetate buffer, pH 4.0; (2) 4 mg/ml of maltose in 0.1 M acetate buffer, 
pH 4.0; or (3) 4 mg/ml of isomaltose in 0.1 M acetate buffer, pH 4.0 and 
incubated for 60 minutes at either 40 or 37oc. Protein was determined 
in the macrophage sonicate according to the method of Lowry. (78). A 
substrate blank containing 0.5 ml of substrate in 0.1 M buffer and 0.5 
ml of saline was incubated with each experimental run. 4 mg/ml of mal-
tose substrate was also prepared in 0.1 M sodium cacodylate-HCl, pH 6.0; 
0.1 M imidazole-HCL, pH 7.0-8.0; and 0.1 M glycine -NaOH, pH 9.0 to 
obtain a pH profile of macrophagec{-1,4 glucosidase activity. Following 
incubation, samples were deproteinized with 1 ml of 1.8% BaOH and 1 ml 
of 2% ZnS04 and centrifuged for 10 minutes at 200 x g. Duplicate 1.0 ml 
aliquots of deproteinized supernatant were added to Hycell cuvette tubes 
and glucose concentration determined by the glucose oxidase method with 
the glucose oxidase reagent dissolved in .025 M tris-HCl buffer to 
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inhibit the maltase present in corrnnercial preparations of glucose oxi-
dase (28). The ofglucosidase activity was measured by the difference 
between the amounts of glucose present in samples incubated at 40 or 
37oc and expressed as ~ glucose per mg of protein per 60 minutes of 
incubation. 
3. Macrophage glycogen synthetase activity 
Uridine diphosphate glucose: o(-1,4-glucana<-4-glucosyl trans-
ferase (E.C. 2.4.1.11), the enzyme responsible for the elongation of 
the outer chains of glycogen, was determined by measuring the amount of 
14c-glucose activity incorporated into macrophage glycogen from UDP-u-14c 
glucose according to a modification of the method described by Gold and 
Segal (48). 1.0 to 2.0 ml of packed 96 hour inflammatory macrophages 
were sonicated in two volumes of 0.1 M glycylglycine buffer (pH 7.4) at 
40C for 2 minutes and the sonicate centrifuged for 10 minutes at 3000 x g 
at 4oc. The assay mixture contained ~mol of UDP-glucose, O.~i of UDP-
glucose -u-14c,26~ol of glycylglycine, pH 7.4, and 20 mg.of glycogen 
in a total volume of 3.8 ml. When the glucose-6-phosphate dependent or 
D form of the enzyme was as,sayed, 0. 01 M glucose-6-phosphate was also 
present. The reaction was initiated by adding 0.2 ml of macrophage 3000 
x g sonicate supernatant to the assay mixture in 25 ml Erlenmeyer flasks 
and incubated at 37oc for 10 minutes with shaking (60/min). The reaction 
was stopped by the addition of 6.0 ml of hot 30% KOH to each flask and 
the contents of the flasks transferred to 40 ml centrifuge tubes and 
heated for 15 minutes in a boiling water bath. Following heating, 0.5 ml 
of saturated NaS04 was added to each centrifuge tube and glycogen preci-
pitated with 14.0 ml of 95% ETOH. The mixture was again heated to boil, 
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cooled for 30 minutes at 4°C and centrifuged for 10 minutes at 200 x g. 
The glycogen-Na2S04 pellets were dissolved in 5.0 ml of distilled water 
and reprecipitated by adding 6.0 ml of 95% ETOH. The tubes were heated, 
cooled and centrifuged as above. The glycogen pellet was dissolved in 
distilled water to a final volume of 3.0 ml and duplicate 1.0 ml sam-
ples of the glycogen solutions were added to 10-15 ml of Phase Combining 
System (PCS) Solubilizer, (Amersham/Searle Corp., Arlington Heights, 
Illinois,) and counted in the Isocap 300 for 10 minutes. Background 
incorporation was determined in samples to which the enzyme was added 
after the addition of KOH to the flask. Enzyme activities are ex-
pressed as nanomoles of glucose transferred from 14c-uridine diphosphate 
glucose (UDPG) to glycogen per 10 minutes per mg of protein. 
4. Macrophage glucose-6-phosphatase activity 
Macrophage glucose-6-phosphatase activity was measured by the 
liberation of inorganic phosphorus from glucose-6-phosphate as described 
by DeDuve (34). Inflammatory macrophages (40-50 x 106 ml) -.vere sus-
pended in 0.25 M sucrose and sonicated for 2 minutes at 40C using a 
Biosonik IV (Brownwill Scientific Inc., Rochester, N.Y.) with micro-
probe. Protein was determined in the macrophage sonicate according to 
the method of Lowry (78). Duplicate 0.5 ml aliquots of macrophage soni-
cate were added to 12 ml centrifuge tubes containing 0.5 ml of .04 M 
glucose-6-phosphate, .001 M EDTA, and .007 M histidine monohydrate, pH 
6.5, and incubated for 10 minutes at 37oc. Enzyme blanks were determined 
in tubes to which the macrophage sonicate was added after the addition 
of 10% TCA and incubated for 10 minutes at 37°C. Reagent blanks were 
prepared by incubating 0.5 ml of the glucose-6-phosphate substrate with 
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0.5 ml of 0.25 M sucrose. Following incubation, 5.0 ml of 10% TCA were 
added to assay and reagent blank tubes and all samples were centrifuged 
for 15 minutes at 200 x g at 4°C. 1.0 ml of deproteinized supernatant 
was added to cuvettes and inorganic p~osphorus was determined by the 
method .of Fiske and Subbarow (47). Activity was expressed as mg phos-
phorus liberated per 10 minutes per mg protein. 
E. Glucogenesis in Inflammatory Macrophages and Polymorpho-
nuclear Leukocytes 
Two ml of cells (20-50 x 106/ml) or derived sonicate were sus-
pended in GFH and added to 25 ml Erlenmeyer flask~ at 4oc. One ml of 
additions was added and all incubations were conducted at 37°C with 
air as the gas phase and the flasks were shaken at 60/minute in a 
Dubnoff metabolic shaking bath. Incubations were terminated by rapidly 
freezing all samples along with appropriate blanks at -2ooc. After 
thawing, samples were deproteinized with 1 ml of 1.8% BaOH and 1 ml 
of 2.0% ZnS04 and the glucostat method (Worthington Biochemical Co., 
Freehold, N.J.) was used to determine glucose concentrations from de-
proteinized supernatants. Glucose concentrations are expressed as~ 
glucose per mg of protein per hour of incubation. 
F. Statistics and Data Analysis 
Throughout the entire study, all results are expressed as the 
mean + the standard error of the mean with the number of independent 
in vitro observations described as "n". Non-paired analysis were em-
ployed, placing the confidence limit at 95% for all experiments. 
I 
CAAP~RIV 
RESULTS 
A. Factors Regulating the Glycogen Content of Inflammatory Macrophages 
1. Inflammatory cellular yields from the rat peritoneal cavity 
Lavage of normal, unstimulated rat peritoneal cavities yielded 
an average 18-20 x 106 mononuclear cells per rat with small macrophages 
and lymphocytes constituting 90% of the cell population recovered. 
Caseinate induction resulted in consistently high'yields of inflammatory 
exudate cells from the rat peritoneum; from the 3 hour exudate, 6-7 x 
107 cells were collected from each rat with greater than 90% of the 
cell population examined being PMNL. The 96 hour inflammatory exudate 
produced 2-3 x 108 cells per rat with inflammatory macrophages accounting 
for 85-90% of the cell population; PMNL and lymphocytes comprised the 
remainder of the exudative population. Approximately 90% of the 96 hour 
inflammatory cell population was observed to adhere to a glass surface 
when incubated for 60 minutes in Leighton tubes; furthermore, the cells 
avidly phagocytized latex beads, o.~ in diameter, and carbon particles 
as determined by light microscopy. 
2. Glycogen content of inflammatory PMNL and macrophages 
The glycogen contents of caseinate-induced inflammatory PMNL and 
macrophages harvested from the rat peritoneum are presented in Table 1. 
The 96 hour in~lammatory macrophage was observed to contain a large in-
tracellular glycogen reserve. When the glycogen level of inflammatory 
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TABLE 1 
GLYCOGEN CONTENT AND DEPLETION IN INFLAMMATORY PMNL AND MACROPHAGES a.) 
Number of Glycogen Content 
Incubation 
Cell Type Samples JAg glycogen/106 cells 
Inflammatory 
PMNL 
Control .. 60 min at 4°C 4 
60 min in GFH at 37°C 4 
Inflammatory 
Macrophages 
Control - 60 min at 4oc 7 
60 min in GFH at 37°C 6 
9-55.:!:. 0.44 
5.53.:!:. 0.36 
11.79 .:!:. l. 59 
5.78.:!:. 0.58 
% of control 
100 
58 
100 
49 
a.) 4.0 ml (20-40 x 106/ml) of inflammatory macrophages were incubated in GFH for 60 minutes 
at either 4° or 37°C. Glycogen content is expressed asfog glycogen per 106 cells. 
+:-
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macrophages was compared with the 3 hour exudate PMNL,'.there was no sig-
nificant difference in the glycogen levels of these two inflammatory 
cell populations. Furthermore, when either inflammatory PMNL or macro-
phages were incubated in glucose-free,Hanks (GFH) media for 60 minutes, 
both cell populations exhibited a labile intracellular glycogen pool 
as demonstrated by an approximately 50% reduction in either inflammatory 
cell's carbohydrate reserve. 
Figure 1 depicts the effect of incubation in GFH on the glycogen 
content in inflammatory macrophages. Increasing the length of incuba-
tion in a glucose-free media to 120 minutes did not further reduce the 
glycogen levels in inflammatory macrophages. This inability to further 
deplete the intracellular glycogen store suggests that only a certain 
fraction of macrophage glycogen is available for rapid mobilization as 
a fuel reserve. 
3. Effect of anaerobiosis and phagocytosis on glycogen 
content in inflammatory macrophages 
Since the peritoneal macrophage has been demonstrated to ulti-
mately rely on glycolytic mechanisms to meet energy demands under 
anaerobic conditions (85), it was of interest to determine whether in 
vitro incubations of inflammatory macrophages in the presence of a ni-
trogen atmosphere would markedly affect macrophage glycogen stores 
(Table 2). During 60 minutes of incubation under anaerobic conditions 
in a glucose-free media, inflammatory macrophages did not demonstrate 
a further reduction in their glycogen content when compared to macro-
phages incubated similarly with air as the gas phase. 
Furthermore, since leukocyte glycogen breakdown has been shown 
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FIGURE 1 
EFFECT OF IN VITRO INCUBATION IN GFH 
30 
ON MACROPHAGE GLYCOGEN CONTENT 
60 
minutes 
120 
4.0 ml of macrophages (20-40 x 106/ml) were incubated at 37°C 
in GFH shaking (60/min) for the various incubation intervals. Glycogen 
content is compared with control value at 4° and expressed as per cent 
of control. Each point represents the mean + standard error of at least 
four experiments. 
TABLE 2 
EFFECT OF ANAEROBIOSIS AND PHAGOCYTOSIS ON THE GLYCOGEN CONTENT 
IN INFLAMMATORY MACROPHAGES 
) Number of Glycogen Content 
In~ubation a. Incubation 
Conditions Samples ~g glycogen/mg Protein 
A. Control - 60 min at 4°C 8 110.3.:!:.. 12.8 
B. 60 min in GFH 8 58.5 .:!:.. 6.12 
c. 60 min + N2 Atmosphere 4 56.0 .:!:.. 11.8 
D. 60 min+ Latex Particles b.) 4 40.0 + 3. 40 c.) 
a.) 4.0 ml of inflammatory macrophages (20-40 x 106 cells/ml) were incubated at 37°C with 
shaking (60/min) for 60 min. Glycogen content is expressed as ~g glycogen/mg protein. 
b.) Latex particles (0.8~dia) were added at a particle to cell ratio of 50:1 in a total 
volume of 0.1 ml in GFH. 
c. ) p {. 05 as compared to group B 
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to be accelerated during phagocytosis in the absence of\adequate glucose 
in the media (23, 107), experiments were undertaken to determine if 
macrophage glycogen provided additional fuel molecules during the course 
of the phagocytic event. When inflammatory macrophages were incubated 
in the presence of latex particles (0.8~ in dia) in a glucose-free media, 
the glycogen content of phagocytizing macrophages was significantly di-
minished when compared to non-phagocytizing macrophages (Table 2). 
4. Effect of glucose and exogenous glycogen on inflammatory 
macrophage glycogen content 
The maintenance of intracellular macrophage glycogen content by 
the addition of either glucose or exogenous glycogen is presented in 
Table 3. Inflammatory macrophages were incubated in the presence of 
lOmM glucose or 10 mg/ml of glycogen (Rabbit Liver Glycogen, Type III, 
Sigma Co., St. Louis, Mo.) for 60 minutes and macrophage glycogen con-
tent determined. The presence of lOmM glucose in the incubation media 
adequately maintained macrophage glycogen content during the 60 minute 
incubation interval. Moreover, the addition of 10 mg/ml of exogenous 
glycogen to the glucose-free medium also enabled macrophages to maintain 
their intracellular glycogen pool. In the presence of exogenous gly-
cogen, the glycogen content of inflammatory macrophages following 60 
minutes of incubation did not differ significantly from those samples 
incubated in the presence of a high glucose load. In addition, incuba-
tion of exogenous glycogen with inflammatory macrophages in an anaerobic 
atmosphere did not significantly diminish the macrophage~'s ability to 
maintain glycogen levels when compared to samples incubated under air 
atmosphere. 
A. 
B. 
c. 
D. 
E. 
TABLE 3 
EFFECT OF GLUCOSE AND EXOGENOUS GLYCOGEN ON INFLAMMATORY MACROPHAGE GLYCOGEN CONTENT 
Incubation Incubation a· ) 
Number of Glycogen Content 
Candi tions Samples jA.g Gl;ycogen/mg Protein % of Control 
Control - 60 min at 4oc 8 110.3 ~ 12.8 c.) 100 
60 min in GFH 8 58.5 ~ 6.12 53 
60 min 
+ lOmM Glucose 6 95.8 ~ 4.20 87 
60 min 
+ lOmg/ml Glycogen b.) 6 85.4 ~ 9.08 75 
60 min 
+ lOmg/ml Glycogen 
+ N2 Atmosphere 3 76.6 + 3.65 70 
a.) 4.0 ml of macrophages (20-40 x 106/ml) were incubated·for 60 min at 37°C with shaking (60/min) 
b.) Rabbit liver glycogen (Sigma Co., St. Louis, Mo.) was dissolved in GFH to a final incubation 
concentration of 10 mg/ml. 
c.) P values in determining significant differences between groups 
gp A vs B 
gp A vs C,D 
gp B vs E 
p <.01 
not significantly different 
P<·os 
+:-
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5~ Effect of glucose or glycogen on the glycogen content 
in glucose-depleted inflammatory macrophages 
One approach to determine by what mechanism exogenous glycogen 
is able to maintain macrophage glycogen content is shown in figure 2. 
Incorporation of exogenous glycogen into the inflammatory macrophage 
glycogen pool could occur by two possible mechanisms, i.e., phagocy-
tosis of macromolecular glycogen particles or by the extracellular 
hYdrolysis of glycogen to glucose with the subsequent transport of 
glucose into the macrophage directed toward glycogen resynthesis. 
Since an adequate glucose supply to maintain glycolytic mechanisms is 
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one necessary requirement for particle ingestion by phagocytic cells 
(23), incubation of inflammatory macrophages in a glucose deficient en-
vironment would therefore suppress phagocytosis of glycogen particles. 
Macrophage glycogen resynthesis from glucose can be adequately stimu-
lated by preincubating macrophage cell suspensions for two hours in a 
glucose-free medium. The addition of lOmM glucose to glycogen-depleted 
inflammatory macrophages initiated a dramatic increase in glycogen re-
synthesis by inflammatory macrophages, reaching control levels by 60 
minutes of incubation. In contrast, the addition of 10 mg/ml of gly-
cogen to macrophages with a low energy reserve in a glucose-free medium 
did not result in any significant changes in macrophage intracellular 
glycogen content. 
6. Incorporation of l4c-U-glucose into inflammatory 
macrophage glycogen 
14c-u-g{ucose was utilized to compare the rates of glycogen 
synthesis in glycogen-laden inflammatory macrophages and glycogen 
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FIGURE 2 
EFFECT OF GLUCOSE (lOmM) OR GLYCOGEN (lOmg/ml) ON GLYCOGEN 
CONTENT IN GLYCOGEN-DEPLETED MACROPHAGES 
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4.0 ml of macrophages (20-40 x 106/ml) were preincubated for 
2 hours at 37°C with shaking (60/min) in GFH. lOmM glucose or 10 mg/ml 
of glycogen were then added and glycogen content determined at 30 minute 
intervals. Ea~h point represents the mean+ standard error of at least 
three experiments. 
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resynthesis in macrophage depleted of their glycogen pools (Figure 3). 
Inflammatory macrophage cell suspension were preincubated in a glucose-
free media at either 4° or 37°C. Following the preincubation period, 
lOmM glucose containing 0.1~ of 14c-U-glucose was added to each flask 
and, following various incubation intervals, macrophage glycogen was 
isolated and r·adioactivity counted from aliquots of dissolved glycogen. 
Glycogen-laden inflammatory macrophages incorporated 14c-U-glucose into 
intracellular glycogen at a rate of 27.2 + 3.8 x 103 dpm of 14c-glucose 
per 30 minutes per gram of cell protein. Glycogen resynthesis in gly-
cogen-depleted.macrophages was determined to be 71.5 + 4.4 x 103 dpm of 
14c-U-glucose incorporated into macrophage glycogen per 30 minutes per 
gram of cell protein. The rate of 14c-glucose incorporation into macro-
phage glycogen was directly related to the length of incubation in both 
macrophage populations (Figure 3). Thus glycogen depleted macrophages 
demonstrated an accelerated rate of glycogen resynthesis and suggests 
a probable inverse relationship between macrophage glycogen concentration 
and the percent of glycogen synthetase in the active form as has been 
observed in such tissues as skeletal muscle (29), cardiac muscle, (62) 
and liver (35). 
7. The influence of a pinocytic activator and insulin in 
stimulating 14c-U-glucose incorporation into macrophage 
glycogen 
Pinocytosis affords the macrophage another mechanism of trans-
porting extracellular solutes by membrane vesicle formation and in-
, 
vagination into the macrophage interior. Numerous factors stimulate 
macrophage pinocytosis including anionic proteins, serum factors, ATP, 
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FIGURE 3 
INCORPORATION OF 14c-U-GLUCOSE INTO INFLAMMATORY MACROPHAGE GLYCOGEN 
EFFECT OF GLYCOGEN DEPLETION ON 14c-GLUCOSE INCORPORATION 
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4.0 ml of macrophages (30-40 X 106/ml) were incubated in the 
presence of lOmM glucose containing O.l~Ci of 14c-U-glucose per flask 
and glycogen isolated from cell pellet. 
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Glycogen depleted macrophages were preincubated for 120 minutes 
at 37°C in GFH prior to the introduction of 14C-glucose. 
Radioactivity was counted from duplicate 0.5 ml samples of 
isolated glycogen dissolved in 1.5 ml of distilled H20. 
Each point represents the mean + standard error of at least 
four experiments. 
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and mucopolysaccharides (24). Since albumin is one such activator of 
macrophage pinocytic activity, experiments were undertaken to determine 
whether activation of pinocytosis increased the incorporation of extra-
cellular 14c-U-glucose into macrophage glycogen (Table 4). Inflammatory 
roacrophages incubated in the presence of 1% albumin doubled their incor-
poration of 14~-U-glucose into macrophage glycogen as compared to cells 
incubated in a glucose-free media alone. 
Insulin has been shown to be without effect in PMN leukocytes in-
cubated in vitro in either augmenting glycogen synthetase activity or 
increasing leukocyte glycogen levels (44). Inflammatory macrophages in-
cubated in the presence of insulin (200~U/ml) did not demonstrate any 
increased incorporation of 14c-U-glucose into macrophage glycogen. How-
ever, the addition of insulin to the incubation media containing 1% al-
bumin significantly decreased 14c-U-glucose incorporation into macro-
phage glycogen when compared to macrophages incubated in the presence 
of 1% albumin alone (Table 4). 
8. 14c-glycogen uptake by inflammatory macrophages 
In view of the apparent significance that exogenous glycogen 
serves as a source of energy reserve to the inflammatory macrophage and 
the lack of any quantitative information concerning the ingestion of 
this important fuel macromolecule, preliminary experiments were under-
taken to determine whether l4c-labelled glycogen could be ingested in 
vitro by inflammatory macrophages. Figure 4 presents a plot of the in 
vitro uptake of 14c-labelled glycogen by inflammatory macrophages in a 
, 
glucose-free media. 14c-glycogen was prepared from rat liver as des-
cribed in Methods and dissolved in GFH containing unlabelled glycogen 
to a final incubation concentration of 10 mg/ml. Using a medium glycogen 
TABLE 4 
INCORPORATION OF l4c-U-GLUCOSE INTO MACROPHAGE GLYCOGEN 
EFFECT OF INSULIN AND ALBUMIN PINOCYTIC ACTIVATION 
Addition to a.) Number of dpm of 14c-U-glucose b.) 
Ineubation Incubation incorporation into 
Medium . Samples glycogen/mg protein/60 min 
lOmM lhc-U-Glucose 
10w1 l4c-U-Glucose 
+ 1% Albumin 
lOmM l4c-U-Glucose 
+ 1% Albumin 
+ 200~U/ml Insulin 
8 
12 
13 
71.9 .:!:. 2.23 
146.9 .:!:. 3.42 
122.8 .:!:. 3.15 
a.) 4.0 ml of macrophages (30-40 x 106 cells/ml) were incubated with 1.0 ml of additions at 
37°C with shaking (60/min) for 60 minutes. 
b.) Radioactivity was counted from duplicate 0.5 ml samples of isolated macrophage glycogen 
dissolved in 1.5 ml of distilled H2o. 
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FIGURE 4 
14c-GLYCOGEN UPTAKE BY INFLAMMATORY MACROPHAGES 
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4.0 ml of macrophages (30-40 x 106 cells/ml) were incubated at 
37oc and 4°C with 0.5 ml of 14c-glycogen in a total volume of 5.0 ml. 
Radioactivity was counted from duplicate 0.5 ml samples of 
isolated macrophage glycogen dissolved in 1.5 ml of distilled H20. 
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0.5 ml of a 100 mg/ml glycogen in GFH contained 90 mg/ml of un-
labeled glycogen + 10 mg/ml of 14c-glycogen. Specific activity of 
final 14c-glycogen solution was approximately 1600 cpm/mg of glycogen. 
concentration of 10 mg/ml containing 16 x 103 cpm/ml of, 14c-glycogen, 
the amount of isotope incorporated into inflammatory macrophage glycogen 
by 15 minutes of incubation corresponded to lOfg of glycogen per mg of 
cell protein. Samples containing 14c-glycogen were incubated at 4°C 
with each experimental run and any activity in the isolated glycogen was 
subtracted from those samples incubated at 37°C. The incorporation of 
14c-glycogen was linear over a 30 minute incubation period utilized in 
these experiments. Assuming no change in the total macrophage glycogen 
level of llOpg of glycogen/mg protein over the 15 minute incubation 
period, the incorporation of exogenous glycogen amounted to approximately 
10% of the total macrophage intracellular pool. 
9. 14c-glycogen uptake in glycogen-depleted inflammatory 
macrophages 
Since glycogen-depleted macrophages manifested a marked inability 
to increase their glycogen content in the presence of exogenous glycogen 
in a glucose-free media, it was of interest to compare the rate of in-
corporation of 14c-glycogen by glycogen-laden and glycogen-depleted in-
flammatory macrophages. In Table 5 is presented the in vitro incorpora-
tion of l4c-labelled glycogen by glycogen laden macrophages and by mac-
rophages depleted of their glycogen reserve by a 2 hour preincubation in 
a glucose-free media. Incorporation of l4c-glycogen by glycogen-depleted 
macrophages w~s markedly depressed in the presence of 10 mg/ml of 14c_ 
labelled glycogen at either 15 or 30 minutes of incubation at 37°C. 
When compared to inflammatory macrophages containing their full comple-
ment of glycogen reserve, the ingestion of exogenous glycogen was de-
pressed nearly 50% in glycogen-depleted inflammatory macrophages, 
TABLE 5 
14C-GLYCOGEN UPTAKE BY INFLAMMATORY MACROPHAGES 
EFFECT OF GLYCOGEN DEPLETION ON 14C-GLYCOGEN UPTAKE 
Macrophage a.) Incubation 
Population Interval 
Number of 
Incubation 
Samples 
l4C-Glycogen Content c.) ~g 14-c Glyco~e~ 
mg Protein b.) %of Control 
Glycogen-Laden 15 min 
Gly~ogen-Depleted 15 min 
Glycogen-Laden 30 min 
Gl~ogen-Depleted 30 min 
4 
4 
4 
4 
29.69 ~ 0.75 
12.56 ~ 0.63 
36.26 ~ 1.60 
21.38 ~ 1.92 
100 
56 
100 
56 
a.) 4.0 ml of macrophages (30-40 x 106/ml) were incubated at 37°C with 0.5 ml of 10 mg/ml of 
14C-glycogen in a total volume of 5.0 ml. 
b.) 
c.) 
Radioactivity was counted from duplicate 0.5 ml samples of isolated macrophage 
dissolved in 1.5 ml of distilled H20. 
14c-glycogen specific activity was 2100 cpm/mg of glycogen. 
glycogen 
/ 
VT 
~ 
58 
suggesting a reduced functional endocytic capacity in inflammatory macro-
phages whose carbohydrate reserve has been severely diminished. 
B. Enzymes Regulating Macrophage Glycogen Metabolism 
l. Macrophage phosphorylase activity 
a. Effect of glycogenolysis on macrophage total 
phosphorylase activity 
Table 6 demonstrates that the initial total phosphorylase ac-
tivity, derived from whole sonicates of 96 hr inflammatory macrpphages, 
was 37.9 ~ l.56~g inorganic phosphorus (Pi) liberated per 15 minutes 
per mg of protein. Total macrophage phosphorylase activity was de-
termined in the presence of 51 -AMP in the reaction mixture. Since it 
was of interest to determine the relative states of macrophage phos-
phorylase activation prior to and during active glycogenolysis, ex-
periments were performed to determine if any change occurred in macro-
phage total phosphorylase activity during 60 minutes of active glyco-
genolysis in a glucose-free media. In Table 6 it is observed that in-
flammatory macrophages incubated in GFH demonstrated no sig-
nificant change in total phosphorylase during the 60 minutes of active 
glycogenolysis. 
b. Effect of exogenous glycogen on macrophage total 
phosphorylase activity 
I 
The activation of macrophage 5 -AMP dependent phosphorylase 
activity by exogenous glycogen is presented in Table 7. Inflammatory 
macrophages were incubated in GFH for 15 minutes in the presence or 
absence of 10 mg/ml of exogenous glycogen in the incubation media. 
Following the 15 minute incubation interval, total phosphorylase 
TABLE 6 
EFFECT OF GLYCOGENOLYSIS ON MACROPHAGE TOTAL PHOSPHORYLASE ACTIVITY a.) 
Number of Total Phosphorylase Activity b.) 
Incubation Incubation 
Intervals Samples 4g P;/15 min/mg protein 
Control 10 37.9~1.56 
15 min 10 42.3 ~ 4.31 
30 min 5 42.3 ~ 5.68 
60 min 5 39.9 ~ 4.50 
a.) 3.0 ml of macrophages were incubated at 37°C with shaking (60/min) in GFH 
b.) Total phosphorylase activity measured in the presence of 5'-AMP was determined on 
whole sonicates in 0.1 M NaF. 
VI 
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TABLE 7 
EFFECT OF EXOGENOUS GLYCOGEN ON TOTAL MACROPHAGE PHOSPHORYLASE ACTIVITY 
Number of 
Additions to a.) Incubation Total Phosphorylase Activity b.) 
Incubation Medium Samples M,g Pi/15 min/mg protein 
Control 
15 min in GFH 
15 min + 10 mg/ml 
Glycogen 
10 
10 
8 
37.9.:!:. 1.56 
42.3.:!:. 4.31 
48.4 + 3.37 
a.) 3.0 ml of macrophages (20-40 x 106 cells/ml) in GFH were incubated with 1.0 ml of 
additions at 37°C with shaking 60/min. 
b.) Total phosphorylase activity was measured in the presence of 5/-AMP and determined 
from whole sonicates in 0.1 M NaF. 
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activity was immediately determined on macrophage sonic~tes. Inflam-
matory macrophages incubated in the presence of 10 mg/ml of glycogen 
significantly increased phosphorylase activity by nearly 30%, whereas 
macrophages incubated in the absence of glycogen did not demonstrate 
/ 
any further activation of 5 -AMP dependent phosphorylase activity. 
c.· The active form of macrophage phosphorylase 
An active or a form of the phosphorylase enzyme, whose activity 
/ is measured in the absence of 5 -AMP, has been demonstrated in such 
tissues as skeletal muscle (26), liver (139) and leukocytes (143, 144). 
, 
Since the form independent of 5 -AMP has been shown to be the fraction 
of phosphorylase activity responsible for initiating glycogenolysis, 
studies were attempted to determine what fraction of macrophage phos-
phorylase activity is in the active form. The active and total phos-
phorylase activities derived from 3000 x g sonicate supernatant is pre-
sented in Table 8. Total macrophage phosphorylase activity measured in 
the presence of 5,-AMP was 41.2 ~ 1.82 g Pi/15 min/mg protein. Macro-
/ phage active phosphorylase activity measured in the absence of 5 -AMP 
was 30.4 ~ 1.86~g Pi/15 min/mg protein. Thus approximately 73% of mac-
rophage phosphorylase activity was in the active form. The macrophage 
phosphorylase activity ratio (active phosphorylase activity/total phos-
phorylase activity) of 0.73 was similar to the 0.75 activity ratio of 
liver phosphorylase (139) and the 0.80 activity ratio of leukocyte 
phosphorylase (143). 
d. Effect of Mg++_ATP on macrophage phosphorylase activity 
The conversion of inactive to active phosphorylase has been shown 
to occur in crude liver extracts (94) and, more recently, in leukocyte 
TABLE 8 
ACTIVE AND TOTAL PHOSPHORYLASE ACTIVITY IN INFLAMMATORY MACROPHAGES 
Number of Macrophage Phosphorylase Activity a.) 
Incubation 
. Samples pg Pi[l_5 min/Plg protein 
Total Phosphorylase 
Activity 
(+ 0.02 M 5/-AMP) 
Phosphorylase a Activity 
(- 0.02 M 5/-AMP) 
Per Cent Activity in the 
Active Form 
9 41.2 + 1.82 
9 30.4 ~ 1.86 b.) 
9 73.1 
a.) Macrophage phosphorylase activity was determined on 3000 x g sonicate supernatants 
in 0.1 M NaF. 
b.) Significantly different from total phosphorylase activity (p<.OOl). 
/ 
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homogenates (143) by a mechanism involving a specific p:rotein kinase 
requiring Mg++ and ATP. In order to determine whether macrophage phos-
pho~ylase was also capable of interconversion of the inactive to active 
form, macrophage 3000 x g sonicate supernatants were incubated with 
o.lM Mg-ATP and the inactive and active phosphorylase activities de-
termin~d (Figure 5). The preincubation of macrophage 3000 x g sonicate 
in O.lM NaF for 30 minutes decreased the percent of macrophage phos-
phorylase in the active form from 73% to 55%. Following this preincu-
bation interval, the introduction of O.lM Mg++_ATP to the samples re-
sulted in a nearly complete conversion of phosphorylase activity to the 
active form by 15 minutes (90% in the active form). Total phosphorylase 
activity measured in the presence of 5"-AMP did not significantly change 
throughout the incubation interval. 
2. Macrophage glucosidase activity 
a. o\-1,4 and ~-1,6 glucosidase activity in inflammatory 
macrophage 
Since acid ~1,4 glucosidase is capable of hydrolyzing maltose, 
linear oligosaccharides, and the outer branches of glycogen to glucose 
and of catalysing the transglucosylation from maltose to glycogen in 
liver, skeletal muscle (58) and in human leukocytes (136), it was of 
interest to determine whether this mechanism of glycogen hydrolysis was 
present in inflammatory macrophages. Table 9 contains the results of 
determinations of~ -glucosidase activities measured at pH 4.0 in whole 
sonicates of 96.hour inflammatory macrophages. Macrophages exhibited 
a large ~-1,4-glucosidase activity of 201.1 ~ 1.07~g of glucose hy-
drolyzed per hour per mg of protein utilizing maltose as the enzyme 
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FIGURE 5 
EFFECT OF Mg-ATP ON 
INFLAMMATORY MACROPHAGE PHOSPHORYLASE ACTIVITY 
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a) Macrophage 3000 xg sonicate supernatants were preincubated 
at 37°C in O.lM NaF for 30 minutes prior to the addition of O.lM Mg+2-ATP. 
b) Per cent in active form was determined by the phosphorylase 
activity ratio '(activity- AMP/activity+ AMP). 
c) Mean+ standard error of four experiments. 
TABLE 9 
o<-GLUCOSIDASE ACTIVITY IN INFLAMMATORY MACROPHAGES a.) 
o{-1,4-Glucosidase b.) o<.-1, 6-Gl.ucosidase b ·) 
4 mg/ml Maltose 8. mg/ml Glycogen 4 mg/ml Isomaltose 
201 ~ 1.07 27.0 ~ 2.0 4.43 ~ 1.08 
(6) (6) (6) 
a.) o<-glucosidase was determined at pH 4.0 from macrophage whole sonicates 
and samples incubated for 60 min at 4° and 37°C. 
b.) o(-glucosidase activity is expressed as~ of glucose hydrolyzed per 
hr per mg protein. 
0\ 
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substrate and 27.0 ~ 2.0~ of glucose hydrolyzed per hour per mg of pro-
tein using glycogen as substrate. ~-1,6-glucosidase activity resulted 
in a very low activity of 4.43 ~ l.08~g of glucose hydrolyzed per hour 
per mg of protein when isomaltose, a dissacharide comprised entirely of 
~-1,6 glucosidic bonds was added as substrate for glucosidase activity. 
b. · Effect of pH on inflammatory macrophage 0<.. -1,4-
glucosidase activity 
Lejeune et al. (76) reported that liver 0(-glucosidase had its 
maximum activity at pH 4.0 and was present in the lysosomal fraction of 
rat-liver homogenates. Figure 6 presents the results of incubating mac-
rophage sonicates with maltose substrate at pH values ranging from 3.0 
to 9.0. Macrophage ~-1,4 glucosidase activity manifested its greatest 
activity at pH 4.0, suggesting that acid pH optimum of macrophage glu-
cosidase activity favors a lysosomal environment. 
3. Macrophage glycogen synthetase activity 
a. I and D forms of macrophage glycogen synthetase 
Table 10 presents the glycogen synthetase or transferase ac-
tivity of inflammatory macrophage 3000 x g sonicate supernatants. 
Macrophage glycogen synthetase was found to exist in two forms, a de-
pendent or D form, requiring the presence of glucose-6-phosphate and an 
independent or I form, manifesting activity in the absence of glucose-
6-phosphate. Macrophage dependent or total glycogen synthetase ac-
tivity measured in the presence of lOmM glucose-6-phosphate was 14.3 + 
2.2mrm of UDP glucose incorporated into macrophage glycogen per 10 
minutes per mg of protein, while the independent or I for.m of macrophage 
glycogen synthetase was 0.84~ of UDP glucose incorporated into glycogen 
FIGURE 6 
EFFECT OF pH ON MACROPHAGE ~-1,4 GLUCOSIDASE ACTIVITY 
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a) 0.5 ml of macrophage sonicate was incubated with 4 mg/ml 
of maltose in a total volume of 1.0 ml for 60 minutes at 4° and 37°C. 
I 
b) Mean+ standard error of nine experiments. 
TABLE 10 
INFLAMMATORY MACROPHAGE GLYCOGEN SYNTHETASE ACTIVITY a.) 
Number of ~oles of UDP glucose 
Incubated incorporated into glycogen/ 
~ Samples 10 min/mg protein 
Total Synthetase Activity 
+ lOmM Glucose-6-Phosphate 
Independent Synthetase Activity 
- lOmM Glucose-6-Phosphate 
Per Cent Activity in the 
Independent Form 
8 
8 
8 
14.3 .:': 2.23 
0.84 + 0.08 
5.9% 
a.) Glycogen synthetase activity was determined on macrophage 3000 x g sonicate 
supernatants in O.lM glycylglycine buffer. 
0\ 
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per 10 minutes per mg protein and represented approximately 6% of the 
total activity. 
b. Effect of glycogen depletion on macrophage glycogen 
synthetase activity 
In view of the observation that preincubation of macrophages in 
a glucose-free media accelerated the rate of l4c-glucose incorporation 
into glycogen, it was of interest to investigate whether an increase in 
the activity of glycogen synthetase was the underlying mechanism for the 
acceleration of glycogen resynthesis in glycogen-depleted macrophages. 
In Table 11 is shown the results of a comparison of macrophage glycogen 
synthetase activity, both in the glucose-6-phosphate independent and 
dependent forms, from glycogen-laden macrophages and macrophages de-
pleted of their glycogen reserve by a 2 hour preincubation in a glucose-
free media. Subsequent to glycogen depletion macrophages exhibited a 
dramatic 267% increase in the glucose-6-phosphate dependent form of the 
enzyme to a value of 38.2 ~ 2.~~ of UDP glucose incorporated into 
glycogen per 10 minutes per mg of protein. The glucose-6-phosphate in-
dependent form of glycogen synthetase was observed to increase over five 
fold to a value of 4.69 ~ 0.7~\m of UDP glucose incorporated into gly-
cogen per 10 minutes per mg of protein. As a consequence of this dra-
matic rise in the independent form of macrophage glycogen synthetase in 
glycogen depleted macrophages, glycogen synthetase activity in the in-
dependent form increased 83% as compared to glycogen laden macrophages. 
4. Macrophage glucose-6-phosphatase activity 
Glucose-6-phosphatase catalyzes the hydrolysis of glucose-6-
phosphate to inorganic phosphate and glucose and its activity has been 
'I :' 
I 
TABLE 11 
EFFECT OF GLYCOGEN DEPLETION ON MACROPHAGE GLYCOGEN SYNTHETASE ACTIVITY a.) 
Number of Glycogen ~ UDPG Glucose 
Incubation Incubation Synthetase Incorporatedinto glycogen/ 
Conditions Samples Activity 10 min/mg protein % of Control 
Glycogen-Laden 
Glycogen-Depleted b · ) 
Glycogen-Laden 
Glycogen-Depleted 
8 
4 
8 
4 
D-form 
D-form 
I-form c ·) 
I-form 
14.3.:!:. 2.23 
38.2 .:!:. 2.15 
0.84 + 0.08 
4.69.:!:. 0.73 
100 
267 
100 
558 
a.) Glycogen synthetase activity was determined on macrophage 3000 x g sonicate supernatant 
in O.lM glycylglycine . . 
b.) Glycogen-depleted macrophages were preincubated for 2 hours at 37°C in GFH. 
c.) Percent activity in I-form in glycogen-laden macrophages = 5.9%. 
Percent activity in I-form in glycogen-depleted macrophages = 10.9%. 
~ 
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reported in liver, kidney and in small intestine (59). \Since glucose-6-
phosphatase represents the final key regulatory step in glycogen me-
tabolism in terms of glucose output, it was of interest to determine 
whether inflammatory macrophages could demonstrate hydrolytic activity 
towards glucose-6-phosphate. Table 12 presents the glucose-6-phosphatase 
activity of inf-lammatory macrophage sonicates in 0.25M sucrose. Macro-
phages displayed a significant glucose-6-phosphatase activity of 1.52 + 
O.llmg Pi/mg protein/10 min, suggesting the enzymatic capability to 
liberate free glucose from intracellular glycogenolytic mechanisms. 
C. Glucogenesis in Inflammatory Macrophages 
Since the macrophage is known to perform trophic functions by 
the ingestion of soluble macromolecules and the subsequent transport 
of digested products back into the immediate extracellular environment, 
it was of interest to determine whether the inflammatory macrophage 
responded trophically to the uptake and intracellular digestion of exo-
genous glycogen by the production and subsequent transport of glucose, 
i.e. glucogenesis, back into the extracellular milieu. 
1. Glucose production in normal and inflammatory exudate cell 
populations 
In Table 13, the glucogenic capability of unstimulated perito-
neal mononuclear cells, inflammatory PMNL and inflammatory macrophages 
is evaluated by measuring the glucose liberated by these cell popula-
tions into a glucose-free media. In the absence of exogenous glycogen, 
there was no significant amount of glucose liberated during a 3 hour 
incubation period by the three peritoneal cell populations. The ad-
dition of 50 mg of glycogen to the incubation flasks significantly 
TABLE 12 
GLUCOSE-6-PHOSPHATASE ACTIVITY IN INFLAMMATORY MACROPHAGES 
Number of 
Incubation Glucose-6-Phosphatase b.) 
Cell Population a.) Samples Acti~ity 
Inflammatory 
Macrophage 
Sonicate 12 1.52 + 0.11 
a.) Inflammatory macrophages were sonicated in 0.25M sucrose at 4°C. 
Duplicate samples were incubated at 4° or 37°C for 30 min. 
b.) Glucose-6-phosphatase activity is expressed as mg Pi/mg protein/10 min. 
-.:] 
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TABLE 13 
GLUCOSE PRODUCTION IN NORMAL AND INFLAMMATORY EXUDATE CELL POPULATIONS a.) 
Glucogenesis -,HS of glucose/mg protein/hour 
Additions to incubation media 
Cell Population No Additions Glycogen (10 mg/ml) 
Glycogen (10 mg/ml) + 
NaF ( 3 mM) 
Unstimulated 
Peritoneal Cells 0 (3)b·) 2.26.!.. 0.78 ( 4) 1.63 .!.. 0.98 (4) 
Inflammatory 
Leukocytes 0.63 .!.. 0.31 (3) 1.42 .!.. 0.13 (3) 1.80 .!.. 1. 06 (4) 
Inflammatory 
Macrophages 0.23 ~ 0.13 (3) 2.68 .!.. 0.35 ( 4) 12.30 ~ 1.75c.)(5) 
a.) Two ml of cells (20-50 x 106/ml) were suspended in GFH in~ total incubation volume of 
3 ml. Incubations were for 180 min. at 37°C. Glucose production is expressed as pg 
of glucose per mg of protein per hour. All data represent the differences as compared 
to control samples incubated at 4°C. 
b.) Number of experiments 
c.) Significantly different from the unstimulated and leukocyte populations (p~.OOl) 
--::J 
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augmented the glucogenic response of all three cell types examined. 
While the addition of 3 mM NaF, a potent glycolytic inhibitor, to the 
incubation media containing exogenous glycogen did not significantly 
alter glucose liberation in either the unstimulated peritoneal mono-
nuclear cells or in the inflammatory PMNL, glucose production by the 
inflammatory macrophage was augmented from 2.68 ~ 0.35~ glucose per 
mg protein per hour to 12.30 ~ 1.75~ glucose per mg protein per hour, 
nearly a six fold increase in the macrophage glucogenic capacity. In 
contrast, macrophages did not manifest a glucogenic response to 3 mM NaF 
when exogenous glycogen was deleted from the incubation media. Further-
more, incubation of 50 mg of glycogen in GFH for 3 hours at 37°C did not 
result in any measurable glucose liberation into the media. 
Glucogenesis by inflammatory macrophages as related to length of 
incubation is represented in Figure 7. The rate of macrophage gluco-
genesis was directly related to the 3 hour incubation interval utilized 
in these experiments. Additional studies have also demonstrated that 
the glucogenic rate was independent of exogenous glycogen concentration 
above 8 mg/m1. These results indicate not only that the rates of re-
actions involved in glycogenolysis and glucogenesis were dependent on 
length of incubation and substrate concentration but also that these me-
chanisms were maintained over the course of incubation time chosen in 
these experiments. 
2. Glucogenesis by inflammatory macrophage cell and sonicate 
preparations 
Table 14 presents the glucogenic response of macrophage whole 
cells and sonicate preparations. Macrophage sonicate preparations when 
compared to intact cells demonstrated a significant increase in the rate 
75 
FIGURE 7 
GLUCOGENESIS BY INFLAMMATORY MACROPHAGES 
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Macrophages were incubated in the presence of 50 mg of glycogen 
and 3mM NaF. Each point represents the mean+ S.E. of at least four 
experiments. 
TABLE 14 
GLUCOSE PRODUCTION BY INFLAMMATORY MACROPHAGE CELL AND SONICATE PREPARATIONS 
Glucogenesis - ,pg glucose/mg protein/hr 
Glycogen 11C mg/ml) + 
Glycogen(lO mg/ml) NaF (3 mM) No Additions 
Macrophage 
Whole Cells 0.23 .:!:. 0.13 (3) 2.68.:!:. 0.35 (4) 12.30.:!:_1.75 (5) 
Macrophage a.) 
Sonicate 3.13.:!:. 0.97 (3) 15.56 .:!:. 2.49 ( 3) 16.71 .:!:. 2.44 ( 3) 
a.) Macrophages (20-50 x 106/ml) were sonicated for two minutes at 4°C in GFH, pH 7.4. 
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of glucose formation either in the absence or presence pf exogenous gly-
cogen. However, the addition of 50 mg of glycogen and 3mM NaF to mac-
rophage sonicate preparatiomresulted in a rate of glucose liberated of 
16.71 ~ 2.4~ of glucose per mg protein per hour comparable to that 
found in the intact cell preparation, i.e. 12.3 + 1. 75flg glucose per mg 
protein per hour. Furthermore, the glucogenic response of 15.56 ~ 2.49~g 
glucose per mg protein per hour demonstrated by the addition of exogenous 
glycogen alone to macrophage sonicates illustrates that the rate of glu-
cose formation from sonicate glycogenolysis in the absence of any meta-
bolic inhibitor is similar to the rate of glucogenesis by intact macro-
phages when substrate utilization is effectively inhibited by NaF. 
3. Effect of acid pH conditions on macrophage glucogenesis 
In order to evaluate the possible role of macrophage acid-hydro-
lytic mechanisms on glycogenolysis and subsequent glucose formation, 
exogenous glycogen was added to macrophage sonicate preparations under 
neutral and acid pH conditions (Table 15). Macrophage sonicates were 
incubated for 180 minutes in a citrate phosphate buffer at either pH 7.0 
or pH 5.0. Glucose production by macrophage sonicates without the ad-
dition of exogenous glycogen demonstrated a probable endogenous glyco-
genolysis at both neutral and acid pH conditions. The addition of exo-
genous glycogen to macrophage sonicates resulted in an augmentation of 
macrophage glycogenolysis. Moreover, macrophage sonicate glycogenolysis 
and glucose formation in the presence of exogenous glycogen was further 
augmented at pH 5.0 when compared to neutral pH conditions. 
4. Substrate and glycoside bond specificity of macrophage 
glucogenesis 
TABLE 15 
THE EFFECT OF pH ON GLUCOSE PRODUCTION BY MACROPHAGE SONICATES 
Macrophage Sonicate a.) Glucogenesis- #g glucose/mg protein/hour 
+ 10 mg/ml Glycogen 
- 10 mg/ml Glycogen 
pH 7.0 
21.63 2:. 3. 70 b. ) 
8 . 50 2:. 1. 29 
pH 5.0 
32.72 2:. 5.02 
9.02 2:. 1.97 
a.) Three ml of macrophage sonicates were incubated in citrate phosphate 
buffer for 180 min. 
b.) Each value represents the mean+ standard error of the mean of 3 
experiments. 
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In view of the fact that o<-1,4 glucosidase prepominates as the 
principal acid glucosidase present within the inflammatory macrophage, 
substrate and glycoside bond specificity of macrophage glucogenesis was 
investigated in intact macrophage preparations (Table 16). Glycogen and 
soluble starch containo<-1,4 and o(-1,6 glycoside bonds linking glucose 
residues and both substrates can vary enormously in their particle size. 
Dextrans are polysaccharides produced by the action of certain bacteria 
(e.g. Leuconostoc mesenteroides) on sucrose and are composed almost en-
tirely of glucose units joined by c<-1,6 glycosidic linkages. Incubation 
of intact inflammatory macrophages with either glycogen or starch re-
sulted in comparable rate of glucogenesis, 12.3 ~ l.75~g of glucose per 
mg protein per hour and 11.00 ~ 0.31~ of glucose per mg protein per hour, 
respectively, while the addition of two different molecular weight dex-
trans failed to liberate any significant amount of glucose. 
5. Effect of cyclic AMP on macrophage glucogenesis 
In order to evaluate the potential role of a phosphorylytic me-
chanism mediated by glycogen phosphorylase on the glucogenic mechanism, 
experiments were performed to determine whether dibutyryl cyclic AMP 
could influence macrophage glucose formation from exogenous glycogen. 
Cyclic AMP and, in the presence of intact cells, the dibutyryl deriva-
tive are nucleotides known to activate phosphorylase kinase and gly-
cogen phosphorylase (56). Macrophages and PMNL were incubated under 
identical conditions in the presence of 50 mg of glycogen, 3mM NaF and 
lmM dibutyryl cyclic AMP for 180 minutes (Table 17). The results in-
dicate that in the inflammatory macrophage, the addition of dbc AMP 
produced a 63% increase in the rate of glucose formation in the presence 
TABLE 16 
SUBSTRATE AND GLYCOSIDE BOND SPECIFICITY OF MACROPHAGE GLUCOGENESIS a.) 
Addition to Number of Glucogenesis 
Incubation Incubation 
Medium a.) Samples ~g glucose/mg protein/hour 
Glycogen 5 12.30.:!:_1.75 
Starch 3 11.00.:!:. 0.31 
Dextran 6 mw= 2 x 10 3 0.28 .:!:. 0.23 
Dextran 3 0.42.:!:. 0.31 
mw= 2 x 105 
a. ) Two ml of macrophages were in cuba ted iri the presence of NaF ( 3 ml1) and 
50 mg of carbohydrate in GFH for 180 min at 37°C. 
co 
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TABLE 17 
EFFECT OF CYCLIC AMP ON MACROPHAGE AND LEUKOCYTE GLUCOGENESIS a.) 
Glucogenesis -~g glucose/mg protein/hour 
. 
Cell Population 
-dbc AMP +dbc AMP (1 rnM) 
Inflammatory 
Leukocyte 1.80 + 1.06 (4) 1. 20 .:!:. 0 . 31 ( 3) 
Inflammatory 
Macrophage 12.20.:!:_1.75 (5) 19.92.:!:. 0.90 (3)b.) 
a.) Two ml of cells were incubated with 10 mg/ml of glycogen and 
3 rnM of NaF in a total volume of 3.0 ml for 180 min. at 37°C 
with or withour 1 mM dbc AMP. 
b.) Significantly different from macrophages incubated without dbc 
AMP (p<. 01). 
()) 
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of exogenous glycogen. In contrast, the inflammatory P~ did not 
exhibit any demonstrable change in their ability to liberate glucose 
from a glycogen source in the whole cell system. 
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DISCUSSION 
The results of this study demonstrate a prominent glycogen 
content in inflammatory macrophages originating from a 96 hour perito-
neal exudate. The inflammatory macrophage glycogen content of 9.55 
~ 0.44.ug glycogen per 106 cells is not significantly different from 
the glycogen content of 3 hour inflammatory leukocytes utilized in 
this study and is also comparable to glycogen values reported for nor-
mal PMN leukocytes (43, 112). Although a quantitative analysis of mac-
rophage glycogen content has not been previously reported, histological 
studies have suggested glycogen to be a significant cytoplasmic con-
stituent of mononuclear phagocytes. Weiss and Fawcett (134) cultured 
chicken buffy coat cells in autologous serum, allowing granulocytes and 
platelets to disintegrate with continuing culture and leaving a uniform 
population of adherent macrophages. During the in vitro culture in-
cubations, macrophages were observed to markedly increase cytoplasmic 
inclusions exhibiting a positive periodic acid-Schiff (PAS) reaction by 
the ingestion of effete cells. Wulff (142) investigated the glycogen 
metabolism of developing macrophages and observed that, parallel to 
maturation, an increase in PAS-positivity occurred. Recently, Dvorak 
et al. (38) demonstrated dense aggregations of glycogen within the 
peripheral pseudopodia of migrating macrophages in capillary tube cul-
tures. Furthermore, in cultures where macrophage migration was 
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inhibited by the presence of sensitized lymphocytes, glycogen-packed 
pseudopodia were less prominent. Interestingly, in the invertebrate 
chiton Liolophura where the phagocytic cell represents the only.known 
host defense mechanism to fore{gn body invasion or tissue injury, wan-
dering macrophages have been collected from the hemolymph and have been 
observed to coritain large aggregations of glycogen particles, at times 
filling more than half of the cell's cytoplasmic space (71). Therefore, 
the present quantitative data discounts the previous notion that the 
PMN leukocyte is the only white blood cell population to contain sig-
nificant stores of glycogen (109, 125) and support~ the histological 
evidence that macrophages can accumulate a large glycogen reserve. 
The acquisition of glycogen by the macrophage at the inflam-
matory locus appears to occur by the active ingestion of cellular de-
bris containing large deposits of glycogen. Quantitative studies on 
inflammatory leukocyte glycogen content have recently been conducted 
on guinea pig blood and exudate leukocytes (111). The glycogen content 
of leukocytes entering the inflammatory site increased dramatically when 
compared to control peripheral blood leukocytes. The mean glycogen con-
tent of peripheral blood leukocytes of 6.5 ~ 1.3 mg of glycogen per 109 
cells was elevated to 28.7 ~ 3.1 mg of glycogen per 109 cells in 24 hour 
exudate leukocytes. Indeed, the glycogen content of inflammatory leu-
kocytes was already significantly elevated after 4 hours following the 
induction of the inflammatory response. Examination of histological 
evidence has repeatedly suggested that exudate macrophages acquire gly-
, 
cogen by the ingestion of leukocyte debris. Wulff (141) demonstrated 
that inflammatory macrophages progressively increased their glycogen 
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content by the ingestion of neutrophil cytoplasmic fragments. Rebuck 
et al. (97)havefurther suggested that the acquisition of PAS- positive 
neutrophilic debris by inflammatory macrophages was apparently depen-
dent upon a functional macrophage carbohydrate metabolism. The authors 
proposed the concept that the depressed phagocytic capability of mac-
rophages originating from insulin-deficient diabetics was due, in part, 
to a failure of macrophages to increase their glycogen reserve. 
The results of in vitro experiments in this study demonstrating 
the uptake by inflammatory macrophages of exogenous glycogen clearly 
arein agreement with the histological evidence tha~ macrophages areca-
pable of ingesting glycogen at the inflammatory site. Macrophages were 
able to incorporate 14c-labelled glycogen into intracellular glycogen 
stores, amounting to nearly 10% of the total glycogen content in a 15 
minute incubation period. Furthermore, inflammatory macrophages demon-
strated a profound increase in 14c-glycogen uptake at 37°C as compared 
to incubation at 4°C, suggesting that the labelled glycogen was not 
merely being adsorbed to the macrophage membrane during the incubation 
interval. Moreover, macrophages were able to maintain their glycogen 
stores not only by the provision of glucose to the incubation media 
but also by the ingestion of exogenous glycogen in a glucose-free en-
vironment. These results suggest that the macrophage at the inflam-
matory site is able to maintain functional integrity by the ingestion 
of glycogen-containing cellular debris even though adequate substrate 
supply may be interrupted. 
' 
A functional carbohydrate metabolism is mandatory for the provision 
of cellular energy for the active endocytic process in phagocytic cells. 
The findings that, in peritoneal PMN leukocytes and macrophages, gly-
colytic inhibitors prevent phagocytosis, whereas inhibitors of respi-
ration do not indicate that the energy requirement for particle up-
take is ultimately derived from glycolysis (85, 106). Pinocytosis 
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by peritoneal macrophages, in contrast, has been shown to be severely 
depressed by inhibitors of oxidative phosphorylation and respiration 
(16). In vitro incubation under N2 atmospheric conditions did not in-
terfere with glycogen uptake by macrophages in a glucose-free media 
when compared to macrophages incubated under air as the gas phase, sug-
gesting that anaerobic glycolysis provided the necessary energy for 
macrophage glycogen uptake. Whether in vitro glycogen uptake was per-
formed by pinocytic or phagocytic mechanisms was not determined in 
this study, although under in vivo conditions at the inflammatory site, 
both endocytic mechanisms would be operative in the ingestion of soluble 
glycogen or aggregates of the glycogen macromolecule. 
The investigation into the alteration of macrophag~ glycogen 
content during phagocytosis was an attempt to gain further insight into 
the functional significance of the macrophage glycogen reserve. Studies 
examining the metabolic perturbations during phagocytosis by either leu-
kocytes or macrophages have demonstrated a significant stimulation in 
glucose utilization during the phagocytic event (23, 135). The role of 
leukocyte glycogen as an energy store to be utilized during phagocytosis 
has been proposed by Scott (109). Indeed, several studies have reported 
leukocyte glyco£en levels to be depleted in vitro during phagocytosis 
(6, 23, 120). Inflammatory macrophages incubated in the presence of 
latex particles were observed to significantly accelerate glycogenolysis 
in the absence of glucose when compared to non-phagocytizing controls. 
Thus the evidence suggests that the inflammatory macrophage glycogen 
reserve can also be called upon to provide for the augmented glucose 
demands during phagocytosis. 
Incubation for 60 minutes in a glucose-free media mobilized 
half of the ma~rophage glycogen supply, however, incubation for longer 
intervals did not further deplete endogenous glycogen stores. The in-
ability to mobilize the entire glycogen reserve in macrophages has not 
been determined, although studies involved in the molecular structure 
of glycogen have revealed that apparently only 60% of the total glucose 
residues forming the outer linear chains of the .glycogen molecule are 
readily accessible to the action of phosphorylase (115). Additional 
support for the role of macrophage glycogen in maintaining active 
phagocytic mechanisms was provided utilizing glycogen-depleted macro-
phages. The results in this in vitro study demonstrate that the addition 
of exogenous glycogen in a glucose-free media to macrophages,whose energy 
stores have been depleted did not increase macrophage glycogen levels to 
initial control values, although glycogen-depleted macrophages readily 
synthesized glycogen when extracellular glucose was available. The de-
pression of macrophage ·phagocytic ability in glycogen-depleted cells 
was further supported by the fact that the uptake of 14c-labelled glyco-
gen by glycogen-depleted macrophages in a glucose-free media was de-
pressed nearly 50% when compared to glycogen-laden macrophages. These 
results suggest that the depletion of macrophage carbohydrate reserve 
may significantly reduce the capacity of inflammatory macrophages to par-
ticipate in the inflammatory reaction by depressing macrophage function 
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when glucose is not readily available. 
The in vitro incorporation of 14c-glucose into macrophage gly-
cogen offers some insight into the changing balance of synthesis at 
different glycogen loads. The rate of glycogen synthesis in inflam-
matory macrophages partially depleted of their glycogen reserve was ac-
celerated more than three-fold when compared to glycogen-laden cells 
when incubated in the presence of 14c-U-glucose. These results were 
consistent with similar observations made in the PMN leukocyte (109, 
111) and in glycogen-depleted human cytotrophoblastic cells -- a cell 
line that relies heavily on glycogen as an energy source (89). The 
in vitro results in the present study raise the possibility that a re-
lationship exists between the initial glycogen content of macrophages 
and the rate of incorporation of glucose into glycogen. In skeletal 
muscle (75) and liver (35), glycogen decreases its own synthesis non-
hormonally by inhibition of glY,cogen synthetase D phosphatase, the en-
zyme that converts synthetase D to synthetase I. It was suggested by 
Wang et al. (132) that glycogen reple~ion of PMN leukocytes is as-
sociated with a rapid change from the D-form of the enzyme to the I-form 
with a small change in total enzyme activity. More recently, Scott and 
Cooper (111) observed a significant elevation in glycogen synthetase ac-
tivity in exudate leukocytes when compared to blood leukocytes and at-
tributed the change in enzyme activity to an increase in the glucose-6-
phosphate dependent (D) form of the enzyme. 
The present results clearly demonstrate the activity of UDP 
glucose-glucan glucosyl transferase (i.e. glycogen synthetase) in macro-
phage sonicates. Macrophage glycogen synthetase activity independent of 
glucose-6-phosphate (I-form) was equal to 5.9% of the total (I and D) 
activity. Furthermore, when macrophages were incubated for 2 hours in 
a glucose-free media, the I activity increased to nearly 11%. This two 
fold increase in I activity suggests a decreased inhibitory effect of 
glycogen on the synthetase phosphatase. A similar glycogen synthetase 
D to I conversi~n has recently been reported in the human PMN leukocyte 
(132) and also in human lymphocytes {57). Depletion of macrophage gly-
cogen content for 2 hours significantly increased glycogen synthetase 
activity not only in the glucose-6-phosphate independent or I form but 
also in the dependent or D form. In liver, the activation of glycogen 
synthetase (D to I conversion) involves a dephosphorylation catalyzed by 
a specific phosphatase, thus the activity of glycogen synthetase, like 
that of phosphorylase, appears to depend on a finely tuned regulatory 
mechanism between the activities of kinases and phosphatases. The pre-
sent evidence suggests such a regulatory mechanism for glycogen synthesis 
is operational within the inflammatory macrophage and furthermore, that 
alterations in glycogen levels within the cell will exert a profound in-
fluence on the macrophage glycogen synthetic machinery. 
Insulin, a potent stimulator of glycogen synthetic mechanisms 
in adipose tissue and skeletal muscle, failed to increase l4c-glucose in-
corporation into macrophage glycogen at an insulin concentration of 200fU/ml. 
These results support the conclusions of Esmann. ( 44) who also failed to 
find any in vitro effect of insulin at physiological concentrations on 
glucose transport or glycogen synthesis in the PMNL, although prolonged 
incubation and high insulin concentration (lU/ml) did result in a non-
specific increase in glucose transport. However, the addition of 1% 
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albumin to the incubation media significantly doubled the in vitro in-
corporation of 14c-glucose into macrophage glycogen in a 60 minute in-
cubation period. Cohn and Parks (24) have investigated the pinocytosis-
inducing effect of a number of molecular species and have found certain 
proteins, in particular plasma albumin, to be potent stimulators of ve-
sicle formation in macrophages. The addition of insulin to the media 
containing albumin did not further enhance 14C-glucose incorporation into 
macrophage glycogen. Thus the present results suggest that stimulation 
of macrophage pinocytosis results in an increased transport of extracell-
ular glucose, offering endocytosis as a mechanism facilitating glycogen 
synthesis by increasing the incorporation of available extracellular 
glucose. 
The demonstration of macrophage phosphorylase activity indicates 
that, in view of the broad variation in macrophage energy demands at the 
inflammatory site, glycogen mobilization is controlled by a finely balanced 
regulatory mechanism. Rapid glycogenolysis is accomplished'bY the acti-
vation of glycogen phosphorylase and is controlled by a complex cascade 
of phosphorylation-dephosphorylation reactions. Green and Cori (Sl) were 
the first to isolate rabbit skeletal muscle phosphorylase and found 
readily interconvertible active and inactive forms. Sutherland et al. 
(123) characterized the two forms of phosphorylase in liver homogenates 
and demonstrated that the conversion of the inactive to active form re-
quired the presence of ATP, Mg++ and the enzyme phosphorylase b kinase. 
Distinct differences exist in the phosphorylase activity from these two 
tissues. The inactive skeletal muscle enzyme becomes active in the pre-
sence of AMP, while the active form has an activity independent of AMP. 
In contrast, the inactive liver enzyme demonstrates little activity 
even in the presence of the nucleotide, whereas the active form is 
stimulated only 40% by AMP. Detailed studies on the protein kinases 
responsible for the phosphorylation of muscle phosphorylase b has re-
vealed that they also occur as active and inactive forms. Studies by 
Krebs et al. (7·4) have shown that the conversion of the inactive to 
active form of phosphorylase b kinase takes place on incubation with 
ATP and Mg++, resulting in the phosphorylation of the inactive form. 
Maddaiah and Madsen (79) have demonstrated that 60% of resting liver 
phosphorylase activity is in the active form while resting skeletal 
muscle phosphorylase activity is predominantly in the b or inactive 
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form (72). The levels of cofactors and substrates in the cell have been 
shown to influence the interconversion reactions of phosphorylase and 
synthetase. Krebs et al. (74) have demonstrated that elevated glycogen 
levels stimulate the phosphorylase b to a conversion and also the acti-
vation of phosphorylase b kinase whereas, increased glycogen .. levels in-
hibited the synthetase D to I conversion (128). 
Determination of leukocyte phosphorylase activity demonstrated 
a behavior similar to that found in liver in that it was possible to 
activate leukocyte phosphorylase activity in vitro by glucagon (137). 
Recently, Yunis and Arimura (143) examined the properties of glycogen 
phosphorylase in rat chloroma cells, a tumor composed entirely of im-
mature granulocytes, and noticed that leukocyte phosphorylase exhibited 
considerable activity in the absence of AMP and thus resembled liver 
phosphorylase. The present results of phosphorylase assays in inflam-
matory macrophage extracts indicate that a significantly large fraction 
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of the total phosphorylase activity exists in the active form (73%), 
thus, in this one respect, macrophage phosphorylase activity resembled 
leukocyte and liver phosphorylase activity. Total phosphorylase ac-
tivity did not significantly change during a l hour period of glyco-
genolysis in a glucose-free media, however, phosphorylase activity in-
creased significantly 15 minutes following the addition of exogenous 
~lycogen when compared to initial control values, again comparable to 
liver phosphorylase. Conversion of inactive to active liver phosphory-
lase has been shown to occur readily in the presence of Mg++ and ATP 
(94). Macrophage active phosphorylase activity was markedly enhanced 
in macrophage sonicates incubated in the presence of O.lM Mg++_ATP fol-
lowing the partial inactivation of the active form by a 30 minute pre-
incubation. The results suggest that the Mg++_ATP stimulation of macro-
phage active phosphorylase activity is similar to those mechanisms des-
cribed in liver and muscle. The activation of this protein kinase in 
these tissues by Mg++_ATP is strongly stimulated by cyclic AMP. The 
now classic studies by Sutherland and Rall (122) on the physiology of 
cyclic AMP have demonstrated that phosphorylase activation via the 
adenyl cyclase system provides rapid glycogenolysis and increased glu-
cose output by liver preparations. In support of this concept, Reik 
et al. (10~ have localized a hormone-sensitive adenyl cyclase activity 
in reticuloendothelial cells of the liver utilizing both cytochemical 
and biochemical techniques. In addition, alveolar macrophages have been 
found to exhibit a significant increase in the intracellular level of 
cyclic AMP and thus suggesting a link between particle uptake and the 
initiation of metabolic events requiring the accelerated expenditure 
93 
of energy in the form of glycogenolysis (114). Thus the glycogen mo-
bilization via phosphorylase by the, inflammatory macrophage may also 
respond in a similar fashion via a hormone-sensitive adenyl cyclase me-
chanism that would function in rapidly providing glucose to meet the 
substrate demand of the macrophage at the inflammatory locus. 
The pre'sence of an acid {)(,-glucosidase in inflammatory macro-
phages provides an alternate mechanism for the degradation of the gly-
cogen molecule. This is the only known lysosomal enzyme capable of de-
grading glycogen. Jeffrey et al. (64) have recently purified an ~­
glucosidase from the lysosomal fraction of rat liver homogenates and 
have demonstrated that the enzyme had both o(-1,4 and o(.-1,6 glucosidase 
activity. Hers (58) initially demonstrated the deficiency of a lyso-
somal acid maltose, c<-1,4 glucosidase, in the livers of patients with 
Pompe's disease (Type II glycogenesis), a fatal disorder characterized 
by the accumulation of glycogen in the heart, skeletal muscle, brain, 
liver and kidney. Williams (136) measured <::>(-glucosidase a'ctivity in 
human PMN leukocytes from normal subjects and from patients with Type 
II glycogenesis and demonstrated that leukocytes from patients with 
Pompe's disease display approximately one half the activity of the 
normal controls. 
Hsia et al. (61) have characterized an o<-glucosidase in human 
PMN leukocytes and were able to show activity with maltose as a substrate; 
however, no ~-1,6 glucosidase activity was observed utilizing isomaltose 
as substrate. The results of the present study utilizing the macrophage 
indicate a prominent o(,-1,4 glucosidase activity measured at pH 4.0 with 
maltose as substrate. Furthermore, that only ~-1,4 glucosidase activity 
was manifest in macrophage sonicates and negligible ~-+,6 glucosidase 
activity was observed is comparable to the results found in the PMN 
leukocyte. The determination of a 4.0 pH optimum for macrophage o<-
1,4 glucosidase activity is in agreement with results described for 
liver o( -1,4 glucosidase (58) and in PMN leukocytes (136) and strongly 
suggests a probable lysosomal origin within the macrophage for the acid 
glucosidase activity. Therefore, the identification within macrophages 
of a hydrolytic degradative mechanism for glycogen indicates that sub-
sequent to the discharge of lysosomal hydrolases into a glycogen-con-
taining phagocytic vacuole, lysosomal glucosidase could readily attack 
the outer linear branches of the glycogen molecule providing available 
free glucose for macrophage functional energy demands. 
In view of the fact that glucose-6-phosphatase provides the 
final enzymatic link in the provision of free extracellular glucose 
from the glycogenolytic sequence, particular interest is raised in this 
study when glucose-6-phosphatase activity was observed in maGrophage 
sonicates. It is generally accepted that glucose-6-phosphatase acti-
vity is manifested predominantly in those organs which function in the 
regulation of blood glucose. Thus, Hers and DeDuve (59) found glucose-
6-phosphatase activity greatest in liver, kidney and in small intestine. 
Although no glucose-6-phosphatase activity has been reported biochemi-
cally in other white blood cells (61, 109), the blood platelet however, 
does contain measurable amounts of glucose-6-phosphatase (52). Recent 
histochemical evidence revealed that glucose-6-phosphatase activity was 
localized in rat and mouse RES cells, in particular, alveolar macro-
phages and Kupffer cells of the liver (104). The present evidence 
supplies the quantitative data in support of the histochemical demon-
stration of glucose-6-phosphatase activity in macrophages. 
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The functional significance of glucose-6-phosphatase in RES 
cells has not been previously investigated. The active phosphorylytic 
attack of macrophage glycogen by phosphorylase would result in the for-
mation of glucase-6-phosphate which predominantly would be further me-
tabolized via glycolytic or hexose monophosphate shunt pathways to 
meet macrophage energy demands. However, the presence of glucose-6-
phosphatase in inflammatory macrophages provides a third alternative to 
the metabolism of glucose-6-phosph~te, whereby the hydrolytic attack on 
the molecule would result in the formation of free glucose. Therefore, 
the macrophage at the inflammatory site is equipped with the full com-
plement of glucogenic enzymes and is capable enzymatically of supplying 
glucose to its extracellular environment. Thus the present characteri-
zation of glycogenolytic and glucogenic enzymes within the inflammatory 
macrophage reveals an additional trophic functional role for,the large 
carbohydrate supply ingested and stored by the inflammatory macrophages. 
The process of glucogenesis, i.e. the liberation of glucose, 
was demonstrated in vitro in the peritoneal exudate cells and significant 
increases were observed in macrophages in the presence of glycogen and 
NaF, a glycolytic inhibitor. In contrast, neither inflammatory PMN leu-
kocytes nor unstimulated peritoneal mononuclear cells responded by aug-
mented glucose liberation when exogenous glycogen and the glycolytic in-
hibitor were added. The use of a glycolytic inhibitor in vitro to ex-
aggerate the glucogenic response by inflammatory macrophages may mimic 
the in vivo situation whereby the glycolytic pathway is depressed by a 
decrease in intracellular pH initiated by the release of acid hydrolases 
into the cytosol. In support of this concept, Halpern et al. (53) re-
cently compared the rate of glycolysis in leukocytes incubated in media 
of low pH values and found that the inhibition of glycolysis was due to 
an inhibition of the activity of phosphofructokinase, a key regulatory 
enzyme of the glycolytic pathway. 
Recent studies by Cohn and Ehrenreich (20) relevant to the me-
chanisms involved in the uptake of digestible and nondigestible carbo-
hydrates by cultured macrophages have demonstrated that large carbohy-
drate molecules are pinocytized and stored within lysosomal associated 
vacuoles. Intralysosomal hydrolysis of carbohydrates then takes place 
with the formation of utilizable monosaccharides which escape from 
the vacuole. It appears reasonable to speculate that such a mechanism 
is employed following the ingestion of glycogen-contai~ing debris from 
the inflammatory environment. The resulting release of glucose from the 
phagocytic vacuole would then be either further metabolized ·or liberated 
from the macrophage and utilized by ongoing reparative processes at the 
inflammatory site. 
In an attempt to extend these observation~macrophage sonicate 
preparations were employed to investigate the hydrolytic degradation of 
glycogen by inflammatory macrophages. The rate of glucogenesis in macro-
phage whole cells was found to be comparable to the rate of glycogenolysis 
in macrophage sonicates indicating that macrophage lysosomal glucosidase 
released upon sonication could account for the observed rate of glucose 
liberation in the intact macrophage when glucose utilization was de-
pressed. Glycogen and starch are composed of D-glucose units linked by 
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o{-1,4 and o(-1,6 glycoside bonds whereas dextrans are\polysaccharides 
composed entirely of glucose units joined by ~-1,6 glycoside bonds. 
A comparison of the hydrolytic action by macrophage sonicates on large 
molecular weight polysaccharides revealed that glucogenic activity was 
manifest only in the presence of carbohydrates where ~-1,4 glycoside 
bonds are prominent. Thus these present studies concur with the enzyma-
tic demonstration that c<-1,6 glucosidase is not active within the mac-
rophage lysosome. Although glucosi~ase activity in macrophage subcellu-
lar compartments by fractionation techniques was not determined in this 
study, the probable lysosomal origin of the hydr~lytic activity on the 
glycogen molecule was inferred when exogenously added glycogen was more 
rapidly hydrolyzed to glucose by macrophage sonicates under acid pH 
conditions favored by lysosomal hydrolases. 
An important functional role for phosphorylase as a degradative 
process involved in macrophage glycogen breakdown was illustrated by the 
in vitro addition of dibutryl cyclic AMP to macrophages ingesting exo-
genous glycogen. Macrophage glycogenolytic and glucogenic mechanisms 
in intact cells responded to the addition of dibutyryl cyclic AMP by a 
notable increase in the glucose liberated from intact inflammatory mac-
rophages. It is reasonable to assume that dibutyryl cyclic AMP accele-
rated intracellular glycogenolysis by stimulating the activation of mac-
rophage phosphorylase and, coupled with the hydrolytic action of glucose-
6-phosphatase, augmented the liberation of glucose supplied by the acid 
hydrolytic mechanism. Park et al. (88) postulated that adenyl cyclase 
I 
activation during phagocytosis may be the initiating event triggering 
subsequent metabolic alterations during phagocytosis, thus emphasizing a 
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role for phosphorylase activation and the ensuing glycogenolysis in the 
energetics of particle engulfment within phagocytic cells. The present 
study suggests that the degradative pathways involved in glycogenolysis 
within the macrophage include both hydrolytic and phosphorylytic mecha-
nisms and furthermore, that both mechanisms may be operative in sup-
porting macrophage glucogenesis. 
The present studies have demonstrated that the inflammatory mac-
rophage is equipped to harvest a prominent carbohydrate reservoir by the 
ingestion of exogenous glycogen as well as by glycogen synthetic enzymes. 
Furthermore, the dynamic state of macrophage glycogen metabolism has 
been evaluated by the demonstration of a complex glycogen degradative 
apparatus, capable of responding to regulatory control mechanisms, to 
provide additional glucose to meet a wide spectrum of macrophage energy 
demands. The studies illustrating the effect of glycogen depletion on 
the phagocytic ability of the macrophage emphasizes that further in-
vestigation is needed to adequately clarify the physiological role of 
glycogen metabolism within the phagocytic cell. The demonstration of a 
glucogenic capacity within the inflammatory macrophage adds a new di-
mension to macrophage function suggesting that an important nutrient role 
may be served by the macrophage at the inflammatory site in the form of 
glucose provision to assist the.reparative processes of tissue healing 
mechanisms. 
CHAPTER VI 
SUMMARY 
l. , Caseinate-induced 3 hour exudates yielded 6 to 7 x 106 
cells with greater than 90% of the cell population examined being PMNL. 
The 96 hour inflammatory exudate produced 2 to 3 x 108 cells per rat 
with macrophages comprising 85 to 90% of the cell population from the 
peritoneum. 
2. The 96 hour inflammatory macrophage demonstrated a prominent 
glycogen content of 11.79 ~ l.5~;g glycogen per 106 cells or 110.3 ~ 
l2.&~g glycogen per mg of cell protein that was comparable to the glyco-
gen content of the inflammatory PMNL. 
3. Both PMNL and macrophages exhibited a labile intracellular 
glycogen pool that was decreased to approximately 50% of control values 
by incubation in glucose-free Hank's for 60 minutes. Furthermore, when 
macrophages were incubated in the presence of latex particles in a glu-
cose-free medium, the glycogen content of phagocytizing macrophages was 
further diminished when compared to non-phagocytizing macrophages. 
4. Inflammatory macrophages incubated in the presence of 
either 10 mM glucose or 10 mg/ml of exogenous glycogen maintained their 
large glycogen reserve during a 60 minute incubation interval. 
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5. Macrophage glycogen resynthesis from glucose was stimulated 
by preincubation for 2 hours in a glucose-free medium. However, the 
addition of exogenous glycogen to glycogen depleted rnacrophages did not 
result in an elevation of macrophage glycogen content in glycogen de-
pleted cells. 
6. Glycogen synthesis in glycogen depleted macrophages from 
14c-U-glucose was accelerated three-fold when compared to 14c-U-glucose 
incorporation into glycogen from glycogen laden macrophages. 
7. Inflammatory macrophages incubated in the presence of 1% 
albumin doubled their incorporation of 14c-U-glucose into macrophage 
glycogen when compared to cells incubated without the pinocytic acti-
vator. 20~U/rnl of insulin did not enhance the incorporation of 14-c-
U-glucose into macrophage glycogen. 
8. Exogenous 14C-labelled glycogen was readily incorporated 
into the .macrophage glycogen pool. In contrast, incorporation of 14c-
glycogen by glycogen depleted macrophages was markedly depressed. 
9. Inflammatory macrophages exhibited glycogen phosphorylase 
activity that was significantly increased in the presence of exogenous 
glycogen. Macrophage active phosphorylase activity amounted to 73% of 
the total phosphorylase activity and the introduction of 0.1 M Mg++_ 
ATP to macrophage sonicates resulted in a nearly complete conversion 
of macrophage phosphorylase activity to the active form. 
10. Inflammatory macrophages demonstrated considerable~-1,4 
glucosidase activity that manifested its greatest acti~ity at pH 4.0. 
In contrast, macrophages displayed no .o\-1,6 glucosidase activity. 
11. Macrophage glycogen synthetase was found to exist in 
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two forms, a glucose-6-phosphate dependent or D-form and a glucose-6-
phosphate independent or I-form. The I-form amounted to approximately 
6% of the total glycogen synthetase activity. 
12. Glycogen depletion in inflammatory macrophages resulted 
in a dramatic increase in both the I and D-forms of glycogen synthetase. 
Glycogen depletion produced an 83% increase in the I-form as compared 
to glycogen laden macrophages. 
13. Inflammatory macrophages displayed a significant glucose-
6-phosphatase activity suggesting the enzymatic ability to liberate 
free glucose from intracellular glycogenolytic mechanisms. 
14. Glucogenesis, i.e., glucose liberation into the incu-
bation medium was demonstrated by 96 hour inflammatory macrophages 
in the presence of NaF and exogenous glycogen. Macrophage glucogenesis 
was greater at pH 5.0 than at pH 1.0. 
15. Macrophage glucogenesis was marked in the presence of 
either exogenous glycogen or soluble starch while the addition of 
various molecular weight dextrans was ineffective in liberating 
glucose by macrophages. 
16. Glucogenesis in both intact macrophages and sonicate 
preparations was augmented by dbc AMP while PMN leukocyte glucogenesis 
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was not affected by dbc AMP. 
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